{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:02:47Z","timestamp":1780452167172,"version":"3.54.1"},"reference-count":297,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"DOI":"10.1007\/s12031-025-02379-8","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T09:51:38Z","timestamp":1752313898000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Glial Cells in Alzheimer\u2019s Disease: Pathogenic Mechanisms and Therapeutic Frontiers"],"prefix":"10.1007","volume":"75","author":[{"given":"Moumita","family":"Sil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabanita","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishita","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunava","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"key":"2379_CR1","doi-asserted-by":"crossref","unstructured":"Aisen PS, Gauthier S, Ferris SH, Saumier D, Haine D, Garceau D, ... Sampalis J (2011) Tramiprosate in mild-to-moderate Alzheimer\u2019s disease\u2013a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study).\u00a0Arch Med Sci\u00a07(1):102-111","DOI":"10.5114\/aoms.2011.20612"},{"issue":"23","key":"2379_CR2","doi-asserted-by":"publisher","first-page":"7905","DOI":"10.1074\/jbc.RA119.012517","volume":"295","author":"N Ait-Bouziad","year":"2020","unstructured":"Ait-Bouziad N, Chiki A, Limorenko G, Xiao S, Eliezer D, Lashuel HA (2020) Phosphorylation of the overlooked tyrosine 310 regulates the structure, aggregation, and microtubule-and lipid-binding properties of Tau. Journal of Biological Chemistry 295(23):7905\u20137922","journal-title":"J Biol Chem"},{"key":"2379_CR3","doi-asserted-by":"crossref","unstructured":"Agulhon C, Sun MY, Murphy T, Myers T, Lauderdale K, Fiacco TA (2012) Calcium signaling and gliotransmission in normal vs. reactive astrocytes. Front Pharmacol 3:139","DOI":"10.3389\/fphar.2012.00139"},{"key":"2379_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s11658-017-0035-3","volume":"22","author":"E Ampofo","year":"2017","unstructured":"Ampofo E, Schmitt BM, Menger MD, Laschke MW (2017) The regulatory mechanisms of NG2\/CSPG4 expression. Cellular & molecular biology letters 22:1\u20139","journal-title":"Cell Mol Biol Lett"},{"key":"2379_CR5","doi-asserted-by":"crossref","unstructured":"Ando K, Nagaraj S, K\u00fc\u00e7\u00fckali F, De Fisenne MA, Kosa AC, Doeraene E, ... Leroy K (2022) PICALM and Alzheimer\u2019s disease: an update and perspectives.\u00a0Cells\u00a011(24):3994","DOI":"10.3390\/cells11243994"},{"key":"2379_CR6","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.brainresbull.2016.08.018","volume":"126","author":"T Arendt","year":"2016","unstructured":"Arendt T, Stieler JT, Holzer M (2016) Tau and tauopathies. Brain research bulletin 126:238\u2013292","journal-title":"Brain Res Bull"},{"issue":"4","key":"2379_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1474-4422(18)30490-3","volume":"18","author":"AM Arranz","year":"2019","unstructured":"Arranz AM, De Strooper B (2019) The role of astroglia in Alzheimer\u2019s disease: pathophysiology and clinical implications. The Lancet Neurology 18(4):406\u2013414","journal-title":"Lancet Neurol"},{"key":"2379_CR8","doi-asserted-by":"crossref","unstructured":"Atri A (2019) Current and future treatments in Alzheimer\u2019s disease. In:\u00a0Seminars in neurology\u00a0 39(02):227\u2013240. Thieme Medical Publishers","DOI":"10.1055\/s-0039-1678581"},{"key":"2379_CR9","doi-asserted-by":"crossref","unstructured":"Bao M, Hanabuchi S, Facchinetti V, Du Q, Bover L, Plumas J, ... Liu YJ (2012) CD2AP\/SHIP1 complex positively regulates plasmacytoid dendritic cell receptor signaling by inhibiting the E3 ubiquitin ligase Cbl.\u00a0J Immunol\u00a0189(2):786-792","DOI":"10.4049\/jimmunol.1200887"},{"key":"2379_CR10","doi-asserted-by":"crossref","unstructured":"Barbier P, Zejneli O, Martinho M, Lasorsa A, Belle V, Smet-Nocca C, ... Landrieu I (2019) Role of tau as a microtubule-associated protein: structural and functional aspects. Front Aging Neurosci\u00a011:204","DOI":"10.3389\/fnagi.2019.00204"},{"issue":"2","key":"2379_CR11","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3390\/ijms25020817","volume":"25","author":"AF Batista","year":"2024","unstructured":"Batista AF, Khan KA, Papavergi MT, Lemere CA (2024) The importance of complement-mediated immune signaling in Alzheimer\u2019s disease pathogenesis. International Journal of Molecular Sciences 25(2):817","journal-title":"Int J Mol Sci"},{"issue":"2","key":"2379_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/0006-8993(88)90410-6","volume":"463","author":"TG Beach","year":"1988","unstructured":"Beach TG, McGeer EG (1988) Lamina-specific arrangement of astrocytic gliosis and senile plaques in Alzheimer\u2019s disease visual cortex. Brain research 463(2):357\u2013361","journal-title":"Brain Res"},{"issue":"7","key":"2379_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.18632\/oncoscience.64","volume":"1","author":"TN Beck","year":"2014","unstructured":"Beck TN, Nicolas E, Kopp MC, Golemis EA (2014) Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer\u2019s disease. Oncoscience 1(7):486","journal-title":"Oncoscience"},{"key":"2379_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11910-019-0934-y","volume":"19","author":"L Best","year":"2019","unstructured":"Best L, Ghadery C, Pavese N, Tai YF, Strafella AP (2019) New and old TSPO PET radioligands for imaging brain microglial activation in neurodegenerative disease. Current neurology and neuroscience reports 19:1\u201310","journal-title":"Curr Neurol Neurosci Rep"},{"key":"2379_CR15","doi-asserted-by":"publisher","first-page":"104707","DOI":"10.1016\/j.nbd.2019.104707","volume":"134","author":"A Bittar","year":"2020","unstructured":"Bittar A, Bhatt N, Kayed R (2020) Advances and considerations in AD tau-targeted immunotherapy. Neurobiology of disease 134:104707","journal-title":"Neurobiol Dis"},{"key":"2379_CR16","unstructured":"Biogen E (2019) Biogen and Eisai to discontinue phase 3 ENGAGE and EMERGE trials of aducanumab in Alzheimer\u2019s disease [WWW Document].\u00a0\u00a0http:\/\/investors.biogen.com\/news-releases\/news-release-details\/biogen-and-eisai-discontinue-phase-3-engage-and-em.\u00a0Accessed 4.13.20"},{"issue":"1","key":"2379_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0165-5728(97)00054-4","volume":"77","author":"C Bonaiuto","year":"1997","unstructured":"Bonaiuto C, McDonald PP, Rossi F, Cassatella MA (1997) Activation of nuclear factor-\u03baB by \u03b2-amyloid peptides and interferon-\u03b3 in murine microglia. Journal of neuroimmunology 77(1):51\u201356","journal-title":"J Neuroimmunol"},{"key":"2379_CR18","doi-asserted-by":"crossref","unstructured":"Bouvier DS, Jones EV, Quesseveur G, Davoli MA, Ferreira TA, Quirion R, ... Murai KK (2016) High resolution dissection of reactive glial nets in Alzheimer\u2019s disease.\u00a0Sci Rep\u00a06(1):24544","DOI":"10.1038\/srep24544"},{"key":"2379_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00401-009-0601-5","volume":"119","author":"M Bradl","year":"2010","unstructured":"Bradl M, Lassmann H (2010) Oligodendrocytes: biology and pathology. Acta neuropathologica 119:37\u201353","journal-title":"Acta Neuropathol"},{"key":"2379_CR20","doi-asserted-by":"publisher","first-page":"105752","DOI":"10.1016\/j.nbd.2022.105752","volume":"170","author":"E Buhl","year":"2022","unstructured":"Buhl E, Kim YA, Parsons T, Zhu B, Santa-Maria I, Lefort R, Hodge JJ (2022) Effects of Eph\/ephrin signalling and human Alzheimer\u2019s disease-associated EphA1 on Drosophila behaviour and neurophysiology. Neurobiology of Disease 170:105752","journal-title":"Neurobiol Dis"},{"issue":"7","key":"2379_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrd2605","volume":"7","author":"G Burnstock","year":"2008","unstructured":"Burnstock G (2008) Purinergic signalling and disorders of the central nervous system. Nature reviews Drug discovery 7(7):575\u2013590","journal-title":"Nat Rev Drug Discov"},{"issue":"6","key":"2379_CR22","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1469-7580.2005.00458.x","volume":"207","author":"AM Butt","year":"2005","unstructured":"Butt AM, Hamilton N, Hubbard P, Pugh M, Ibrahim M (2005) Synantocytes: the fifth element. Journal of anatomy 207(6):695\u2013706","journal-title":"J Anat"},{"key":"2379_CR23","doi-asserted-by":"crossref","unstructured":"Caglayan S, Takagi-Niidome S, Liao F, Carlo AS, Schmidt V, Burgert T, ...Willnow TE (2014) Lysosomal sorting of amyloid-\u03b2 by the SORLA receptor is impaired by a familial Alzheimer\u2019s disease mutation.\u00a0Sci Transl Med\u00a06(223):223ra20-223ra20","DOI":"10.1126\/scitranslmed.3007747"},{"key":"2379_CR24","doi-asserted-by":"crossref","unstructured":"Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, ... Banati RB (2001) In-vivo measurement of activated microglia in dementia.\u00a0\u00a0Lancet\u00a0358(9280):461-467","DOI":"10.1016\/S0140-6736(01)05625-2"},{"key":"2379_CR25","doi-asserted-by":"crossref","unstructured":"Cao H, Zhou X, Chen Y, Ip FC, Chen Y, Lai NC, ... Ip NY (2022) Association of SPI1 haplotypes with altered SPI1 gene expression and Alzheimer\u2019s disease risk.\u00a0J Alzheimers Dis\u00a086(4):1861-1873","DOI":"10.3233\/JAD-215311"},{"key":"2379_CR26","first-page":"1034243","volume":"13","author":"Y Cao","year":"2022","unstructured":"Cao Y, Yu F, Lyu Y, Lu X (2022) Promising candidates from drug clinical trials: implications for clinical treatment of Alzheimer\u2019s disease in China. Frontiers in Neurology 13:1034243","journal-title":"Front Neurosci"},{"issue":"24","key":"2379_CR27","doi-asserted-by":"publisher","first-page":"5731","DOI":"10.1242\/jcs.01505","volume":"117","author":"G Castelo-Branco","year":"2004","unstructured":"Castelo-Branco G, Rawal N, Arenas E (2004) GSK-3\u03b2 inhibition\/\u03b2-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons. Journal of cell science 117(24):5731\u20135737","journal-title":"J Cell Sci"},{"issue":"2","key":"2379_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/tra.12537","volume":"19","author":"AR Chaudhary","year":"2018","unstructured":"Chaudhary AR, Berger F, Berger CL, Hendricks AG (2018) Tau directs intracellular trafficking by regulating the forces exerted by kinesin and dynein teams. Traffic 19(2):111\u2013121","journal-title":"Traffic"},{"key":"2379_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3389\/fnins.2019.00659","volume":"13","author":"XQ Chen","year":"2019","unstructured":"Chen XQ, Mobley WC (2019) Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric A\u03b2 and tau species. Frontiers in Neuroscience 13:659","journal-title":"Front Neurosci"},{"key":"2379_CR30","doi-asserted-by":"crossref","unstructured":"Clayton K, Delpech JC, Herron S, Iwahara N, Ericsson M, Saito T, ... Ikezu T (2021) Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model.\u00a0Mol\u00a0Neurodegener\u00a016:1-16","DOI":"10.1186\/s13024-021-00440-9"},{"key":"2379_CR31","unstructured":"ClinicalTrials. gov (2014) Study to evaluate the safety, tolerability and the effect of BMS241027 on cerebrospinal fluid biomarkers in subjects with mild Alzheimer\u2019s disease [WWW Document], Accessed 5.3.20.\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01492374"},{"key":"2379_CR32","unstructured":"ClinicalTrials.gov (2018a) Safety and immunogenicity of repeated doses of ABvac40 in patients with a-MCI or Vm-AD [WWW Document], Accessed 5.3.20. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03461276"},{"key":"2379_CR33","unstructured":"ClinicalTrials.gov (2019a) Study to evaluate the safety and tolerability of a new drug named Lu AF20513 in patients with mild Alzheimer\u2019s disease [WWW Document], Accessed 5.3.20.\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02388152"},{"key":"2379_CR34","unstructured":"ClinicalTrials.gov (2019b) Study with Lu AF20513 in patients with mild Alzheimer\u2019s disease (AD) or mild cognitive impairment (MCI) due to AD [WWW Document], Accessed 5.3.20.\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03819699"},{"key":"2379_CR35","unstructured":"ClinicalTrials.gov (2019c) A study to evaluate the safety and tolerability of a new drug named Lu AF20513 in patients with mild Alzheimer\u2019s disease [WWW Document], Accessed 5.3.20.\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03668405"},{"key":"2379_CR36","unstructured":"ClinicalTrials.gov (2019d) Safety and efficacy study of gantenerumab in participants with early Alzheimer\u2019s disease (AD) [WWW Document], Accessed 5.3.20. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03444870"},{"key":"2379_CR37","unstructured":"ClinicalTrials.gov (2019e) Safety and efficacy study of gantenerumab in participants with early Alzheimer\u2019s disease (AD) [WWW Document], Accessed 5.3.20. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03443973"},{"key":"2379_CR38","unstructured":"ClinicalTrials.gov (2019f) A study to confirm safety and efficacy of BAN2401 in participants with early Alzheimer\u2019s disease [WWW Document], Accessed 5.3.20.\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03887455"},{"key":"2379_CR39","unstructured":"ClinicalTrials.gov (2019g) Phase 2 study of BIIB092 in participants with early Alzheimer\u2019s disease (TANGO) [WWW Document], Accessed 5.3.20.\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03352557"},{"key":"2379_CR40","unstructured":"ClinicalTrials.gov (2019h) A study to evaluate the efficacy and safety of ABBV-8E12 in subjects with early Alzheimer\u2019s disease [WWW Document], Accessed 5.3.20.\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02880956"},{"key":"2379_CR41","unstructured":"ClinicalTrials.gov (2019i) A study to evaluate the efficacy and safety of RO7105705 in patients with prodromal to mild Alzheimer\u2019s disease [WWW Document], Accessed 5.3.20.\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03289143"},{"key":"2379_CR42","unstructured":"ClinicalTrials.gov (2019j) A study of SEMORINEMAB in patients with moderate Alzheimer\u2019s disease [WWW Document], Accessed 5.3.20.\u00a0https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03828747"},{"key":"2379_CR43","unstructured":"ClinicalTrials.gov (2019l) A study of LY3303560 in participants with early symptomatic Alzheimer\u2019s disease [WWW Document], Accessed 5.3.20. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03518073"},{"issue":"3","key":"2379_CR44","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1523\/JNEUROSCI.19-03-00928.1999","volume":"19","author":"CK Combs","year":"1999","unstructured":"Combs CK, Johnson DE, Cannady SB, Lehman TM, Landreth GE (1999) Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of \u03b2-amyloid and prion proteins. Journal of Neuroscience 19(3):928\u2013939","journal-title":"J Neurosci"},{"key":"2379_CR45","doi-asserted-by":"crossref","unstructured":"Coric V, Salloway S, van Dyck CH, Dubois B, Andreasen N, Brody M, ... Berman RM (2015) Targeting prodromal Alzheimer disease with avagacestat: a randomized clinical trial. JAMA neurology\u00a072(11):1324-1333","DOI":"10.1001\/jamaneurol.2015.0607"},{"issue":"4","key":"2379_CR46","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/jlb.65.4.416","volume":"65","author":"RL Cotter","year":"1999","unstructured":"Cotter RL, Burke WJ, Thomas VS, Potter JF, Zheng J, Gendelman HE (1999) Insights into the neurodegenerative process of Alzheimer\u2019s disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity. Journal of Leukocyte Biology 65(4):416\u2013427. https:\/\/doi.org\/10.1002\/jlb.65.4.416","journal-title":"J Leukocyte Biol"},{"issue":"1","key":"2379_CR47","first-page":"983640","volume":"2012","author":"H Crehan","year":"2012","unstructured":"Crehan H, Hardy J, Pocock J (2012) Microglia, Alzheimer\u2019s disease, and complement. International Journal of Alzheimer\u2019s Disease 2012(1):983640","journal-title":"Int J Alzheimers Dis"},{"key":"2379_CR48","doi-asserted-by":"crossref","unstructured":"d\u2019Errico P, Ziegler-Waldkirch S, Aires V, Hoffmann P, Mez\u00f6 C, Erny D, ... Meyer-Luehmann M (2022) Microglia contribute to the propagation of A\u03b2 into unaffected brain tissue.\u00a0Nat Neurosci\u00a025(1):20-25","DOI":"10.1038\/s41593-021-00951-0"},{"issue":"2","key":"2379_CR49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/ana.21240","volume":"63","author":"A Dal Bianco","year":"2008","unstructured":"Dal Bianco A, Bradl M, Frischer J, Kutzelnigg A, Jellinger K, Lassmann H (2008) Multiple sclerosis and Alzheimer\u2019s disease. Annals of neurology 63(2):174\u2013183","journal-title":"Ann Neurol"},{"key":"2379_CR50","doi-asserted-by":"crossref","unstructured":"Dal Pr\u00e0 I, Chiarini A, Pacchiana R, Gardenal E, Chakravarthy B, F Whitfield J, Armato U (2014) Calcium-sensing receptors of human astrocyte-neuron teams: amyloid-\u03b2-driven mediators and therapeutic targets of Alzheimer\u2019s disease.\u00a0Curr Neuropharmacol 12(4):353-364","DOI":"10.2174\/1570159X12666140828214701"},{"key":"2379_CR51","doi-asserted-by":"crossref","unstructured":"Dani M, Wood M, Mizoguchi R, Fan Z, Walker Z, Morgan R, ... Edison P (2018) Microglial activation correlates in vivo with both tau and amyloid in Alzheimer\u2019s disease.\u00a0Brain\u00a0141(9):2740-2754","DOI":"10.1093\/brain\/awy188"},{"issue":"2","key":"2379_CR52","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S1044-7431(03)00210-0","volume":"24","author":"MR Dawson","year":"2003","unstructured":"Dawson MR, Polito A, Levine JM, Reynolds R (2003) NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Molecular and Cellular Neuroscience 24(2):476\u2013488","journal-title":"Mol Cell Neurosci"},{"key":"2379_CR53","doi-asserted-by":"crossref","unstructured":"Dejanovic B, Wu T, Tsai MC, Graykowski D, Gandham VD, Rose CM, ... Hanson JE (2022) Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer\u2019s disease mouse models. Nature Aging 2(9):837-850","DOI":"10.1038\/s43587-022-00281-1"},{"key":"2379_CR54","doi-asserted-by":"crossref","unstructured":"DeMattos RB, Cirrito JR, Parsadanian M, May PC, O'Dell MA, Taylor JW, ... Holtzman DM (2004) ApoE and clusterin cooperatively suppress A\u03b2 levels and deposition: evidence that ApoE regulates extracellular A\u03b2 metabolism in vivo.\u00a0Neuron\u00a041(2):193-202","DOI":"10.1016\/S0896-6273(03)00850-X"},{"issue":"17","key":"2379_CR55","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.3390\/cells11172728","volume":"11","author":"G Di Benedetto","year":"2022","unstructured":"Di Benedetto G, Burgaletto C, Bellanca CM, Munaf\u00f2 A, Bernardini R, Cantarella G (2022) Role of microglia and astrocytes in Alzheimer\u2019s disease: from neuroinflammation to Ca2+ homeostasis dysregulation. Cells 11(17):2728","journal-title":"Cells"},{"issue":"5","key":"2379_CR56","doi-asserted-by":"publisher","first-page":"908","DOI":"10.4103\/1673-5374.232486","volume":"13","author":"YX Dong","year":"2018","unstructured":"Dong YX, Zhang HY, Li HY, Liu PH, Sui Y, Sun XH (2018) Association between Alzheimer\u2019s disease pathogenesis and early demyelination and oligodendrocyte dysfunction. Neural regeneration research 13(5):908\u2013914","journal-title":"Neural Regen Res"},{"key":"2379_CR57","doi-asserted-by":"crossref","unstructured":"Doody RS, Raman R, Farlow M, Iwatsubo T, Vellas B, Joffe S, ... Mohs R (2013) A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease. N Engl J Med\u00a0369(4):341-350","DOI":"10.1056\/NEJMoa1210951"},{"key":"2379_CR58","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-009-0532-1","volume":"118","author":"C Duyckaerts","year":"2009","unstructured":"Duyckaerts C, Delatour B, Potier MC (2009) Classification and basic pathology of Alzheimer disease. Acta neuropathologica 118:5\u201336","journal-title":"Acta Neuropathol"},{"issue":"8","key":"2379_CR59","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2174\/1567205013666160129095924","volume":"13","author":"D Dzamba","year":"2016","unstructured":"Dzamba D, Harantova L, Butenko O, Anderova M (2016) Glial cells\u2013the key elements of Alzheimer\u2019s disease. Current Alzheimer Research 13(8):894\u2013911","journal-title":"Curr Alzheimer Res"},{"key":"2379_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0184-x","volume":"12","author":"AG Efthymiou","year":"2017","unstructured":"Efthymiou AG, Goate AM (2017) Late onset Alzheimer\u2019s disease genetics implicates microglial pathways in disease risk. Molecular neurodegeneration 12:1\u201312","journal-title":"Mol Neurodegener"},{"key":"2379_CR61","doi-asserted-by":"crossref","unstructured":"Egan MF, Kost J, Tariot PN, Aisen PS, Cummings JL, Vellas B, ... Michelson D (2018) Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease.\u00a0N Engl J Med\u00a0378(18):1691-1703","DOI":"10.1056\/NEJMoa1706441"},{"key":"2379_CR62","doi-asserted-by":"crossref","unstructured":"Emmerling MR, Watson MD, Raby CA, Spiegel K (2000) The role of complement in Alzheimer\u2019s disease pathology. Biochimica et Biophysica Acta (BBA)Mol Basis Dis 1502(1):158-171","DOI":"10.1016\/S0925-4439(00)00042-9"},{"key":"2379_CR63","doi-asserted-by":"crossref","unstructured":"Escartin C, Galea E, Lakatos A, O\u2019Callaghan JP, Petzold GC, Serrano-Pozo A, ... Verkhratsky A (2021) Reactive astrocyte nomenclature, definitions, and future directions.\u00a0Nature Neurosci 24(3):312-325","DOI":"10.1038\/s41593-020-00783-4"},{"issue":"4","key":"2379_CR64","doi-asserted-by":"publisher","first-page":"263","DOI":"10.2217\/nmt-2021-0019","volume":"11","author":"M Ettcheto","year":"2021","unstructured":"Ettcheto M, Cano A, Sanchez-L\u00f3pez E, Verdaguer E, Folch J, Auladell C, Camins A (2021) Masitinib for the treatment of Alzheimer\u2019s disease. Neurodegenerative Disease Management 11(4):263\u2013276","journal-title":"Neurodegener Dis Manag"},{"key":"2379_CR65","doi-asserted-by":"crossref","unstructured":"Ewers M, Biechele G, Su\u00e1rez\u2010Calvet M, Sacher C, Blume T, Morenas\u2010Rodriguez E, ... Franzmeier N (2020) Higher CSF sTREM2 and microglia activation are associated with slower rates of beta\u2010amyloid accumulation.\u00a0EMBO Mol Med\u00a012(9):e12308","DOI":"10.15252\/emmm.202012308"},{"key":"2379_CR66","doi-asserted-by":"crossref","unstructured":"Ewers M, Franzmeier N, Su\u00e1rez-Calvet M, Morenas-Rodriguez E, Caballero MAA, Kleinberger G, ... Alzheimer\u2019s Disease Neuroimaging Initiative (2019) Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer\u2019s disease.\u00a0Sci Transl Med\u00a011(507):eaav6221","DOI":"10.1126\/scitranslmed.aav6221"},{"key":"2379_CR67","doi-asserted-by":"crossref","unstructured":"Eysert F, Coulon A, Boscher E, Vreulx AC, Flaig A, Mendes T, ... Chapuis J (2021) Alzheimer\u2019s genetic risk factor FERMT2 (Kindlin-2) controls axonal growth and synaptic plasticity in an APP-dependent manner.\u00a0Mol Psychiatr\u00a026(10):5592-5607","DOI":"10.1038\/s41380-020-00926-w"},{"issue":"5","key":"2379_CR68","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2174\/1570159X16666180118120239","volume":"16","author":"M Fakhoury","year":"2018","unstructured":"Fakhoury M (2018) Microglia and astrocytes in Alzheimer\u2019s disease: implications for therapy. Current Neuropharmacology 16(5):508\u2013518. https:\/\/doi.org\/10.2174\/1570159X16666180118120239","journal-title":"Curr Neuropharmacol"},{"key":"2379_CR69","doi-asserted-by":"crossref","unstructured":"Feng S, Wu C, Zou P, Deng Q, Chen Z, Li M, ... Yang L (2023) High-intensity interval training ameliorates Alzheimer\u2019s disease-like pathology by regulating astrocyte phenotype-associated AQP4 polarization.\u00a0Theranostics\u00a03(10):3434","DOI":"10.7150\/thno.81951"},{"key":"2379_CR70","doi-asserted-by":"crossref","unstructured":"Fitz NF, Nam KN, Wolfe CM, Letronne F, Playso BE, Iordanova BE, ... Koldamova R (2021) Phospholipids of ApoE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer\u2019s disease.\u00a0Nat Commun\u00a012(1):3416","DOI":"10.1038\/s41467-021-23762-0"},{"issue":"5","key":"2379_CR71","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1192\/bjp.bp.110.080044","volume":"198","author":"OV Forlenza","year":"2011","unstructured":"Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF (2011) Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. The British Journal of Psychiatry 198(5):351\u2013356","journal-title":"Br J Psychiatr"},{"key":"2379_CR72","doi-asserted-by":"crossref","unstructured":"Forny-Germano L, e Silva NML, Batista AF, Brito-Moreira J, Gralle M, Boehnke SE, ... De Felice FG (2014) Alzheimer\u2019s disease-like pathology induced by amyloid-\u03b2 oligomers in nonhuman primates.\u00a0J Neurosci 34(41):13629-13643","DOI":"10.1523\/JNEUROSCI.1353-14.2014"},{"key":"2379_CR73","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnins.2019.00164","volume":"13","author":"EM Foster","year":"2019","unstructured":"Foster EM, Dangla-Valls A, Lovestone S, Ribe EM, Buckley NJ (2019) Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies. Frontiers in neuroscience 13:164","journal-title":"Front Neurosci"},{"issue":"6005","key":"2379_CR74","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1126\/science.1190928","volume":"330","author":"MR Freeman","year":"2010","unstructured":"Freeman MR (2010) Specification and morphogenesis of astrocytes. Science 330(6005):774\u2013778","journal-title":"Science"},{"issue":"12","key":"2379_CR75","doi-asserted-by":"publisher","first-page":"170228","DOI":"10.1098\/rsob.170228","volume":"7","author":"GR Frost","year":"2017","unstructured":"Frost GR, Li YM (2017) The role of astrocytes in amyloid production and Alzheimer\u2019s disease. Open biology 7(12):170228","journal-title":"Open Biol"},{"issue":"2","key":"2379_CR76","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3233\/JAD-160456","volume":"54","author":"Y Fu","year":"2016","unstructured":"Fu Y, Hsiao JHT, Paxinos G, Halliday GM, Kim WS (2016) ABCA7 mediates phagocytic clearance of amyloid-\u03b2 in the brain. Journal of Alzheimer\u2019s Disease 54(2):569\u2013584","journal-title":"J Alzheimer's Dis"},{"issue":"5","key":"2379_CR77","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0149-7634(99)00024-9","volume":"23","author":"E Gahtan","year":"1999","unstructured":"Gahtan E, Overmier JB (1999) Inflammatory pathogenesis in Alzheimer\u2019s disease: biological mechanisms and cognitive sequelae. Neuroscience & Biobehavioral Reviews 23(5):615\u2013633. https:\/\/doi.org\/10.1016\/S0149-7634(99)00024-9","journal-title":"Neurosci Biobehav Rev"},{"key":"2379_CR78","doi-asserted-by":"crossref","unstructured":"Gaugler J, James B, Johnson T, Reimer J, Solis M, Weuve J, ... Hohman TJ (2022) Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement 18:700-789","DOI":"10.1002\/alz.12638"},{"key":"2379_CR79","doi-asserted-by":"crossref","unstructured":"Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, ... Wischik CM (2016) Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer\u2019s disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial.\u00a0Lancet\u00a0388(10062):2873-2884","DOI":"10.1016\/S0140-6736(16)31275-2"},{"issue":"7394","key":"2379_CR80","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature10959","volume":"484","author":"WP Ge","year":"2012","unstructured":"Ge WP, Miyawaki A, Gage FH, Jan YN, Jan LY (2012) Local generation of glia is a major astrocyte source in postnatal cortex. Nature 484(7394):376\u2013380","journal-title":"Nature"},{"issue":"4","key":"2379_CR81","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/jlb.65.4.407","volume":"65","author":"HE Gendelman","year":"1999","unstructured":"Gendelman HE, Folks DG (1999) Innate and acquired immunity in neurodegenerative disorders. Journal of Leukocyte Biology 65(4):407\u2013408. https:\/\/doi.org\/10.1002\/jlb.65.4.407","journal-title":"J Leukocyte Biol"},{"key":"2379_CR82","doi-asserted-by":"crossref","unstructured":"Gerrits E, Brouwer N, Kooistra SM, Woodbury ME, Vermeiren Y, Lambourne M, ... Boddeke EW (2021) Distinct amyloid-\u03b2 and tau-associated microglia profiles in Alzheimer\u2019s disease.\u00a0Acta\u00a0Neuropathol\u00a0141:681-696","DOI":"10.1007\/s00401-021-02263-w"},{"key":"2379_CR83","doi-asserted-by":"publisher","unstructured":"Giulian D, Haverkamp LJ, Li J, Karshin WL, Yu J, Tom D, ...\u00a0 Johnson M (1995) Senile plaques stimulate microglia to release a neurotoxin found in Alzheimer\u2019s brain. Neurochem Int 27(2):119\u2013137. https:\/\/doi.org\/10.1016\/0197-0186(94)00117-G","DOI":"10.1016\/0197-0186(94)00117-G"},{"key":"2379_CR84","doi-asserted-by":"publisher","unstructured":"Giulian D, Haverkamp LJ, Yu JH, Karshin W, Tom D, Li J, ... Johnson M (1996) Specific domains of beta-amyloid from Alzheimer\u2019s plaque elicit neuron killing in human microglia. J Neurosci 16(20):6021\u20136037. https:\/\/doi.org\/10.1523\/JNEUROSCI.16-20-06021.1996","DOI":"10.1523\/JNEUROSCI.16-20-06021.1996"},{"issue":"11","key":"2379_CR85","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1523\/JNEUROSCI.4361-12.2013","volume":"33","author":"S Ghosh","year":"2013","unstructured":"Ghosh S, Wu MD, Shaftel SS, Kyrkanides S, LaFerla FM, Olschowka JA, O\u2019Banion MK (2013) Sustained interleukin-1\u03b2 overexpression exacerbates tau pathology despite reduced amyloid burden in an Alzheimer\u2019s mouse model. Journal of Neuroscience 33(11):5053\u20135064","journal-title":"J Neurosci"},{"issue":"1","key":"2379_CR86","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13311-014-0313-y","volume":"12","author":"GK Gouras","year":"2015","unstructured":"Gouras GK, Olsson TT, Hansson O (2015) \u03b2-amyloid peptides and amyloid plaques in Alzheimer\u2019s disease. Neurotherapeutics 12(1):3\u201311","journal-title":"Neurotherapeutics"},{"key":"2379_CR87","doi-asserted-by":"crossref","unstructured":"Gratuze M, Chen Y, Parhizkar S, Jain N, Strickland MR, Serrano JR, ... Holtzman DM (2021) Activated microglia mitigate A\u03b2-associated tau seeding and spreading.\u00a0J Exp Med\u00a0218(8):e20210542","DOI":"10.1084\/jem.20210542"},{"key":"2379_CR88","doi-asserted-by":"crossref","unstructured":"Gratuze M, Leyns CE, Sauerbeck AD, St-Pierre MK, Xiong M, Kim N, ... Holtzman DM (2020) Impact of TREM2 R47H variant on tau pathology\u2013induced gliosis and neurodegeneration.\u00a0J Clin Inv 130(9):4954-4968","DOI":"10.1172\/JCI138179"},{"key":"2379_CR89","doi-asserted-by":"crossref","unstructured":"Green RC, Schneider LS, Amato DA, Beelen AP, Wilcock G, Swabb EA, \u2026\u00a0 Tarenflurbil Phase 3 Study Group (2009) Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. Jama 302(23):2557\u20132564","DOI":"10.1001\/jama.2009.1866"},{"key":"2379_CR90","doi-asserted-by":"crossref","unstructured":"Griciuc A, Patel S, Federico AN, Choi SH, Innes BJ, Oram MK, ... Tanzi RE (2019) TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer\u2019s disease.\u00a0Neuron\u00a0103(5):820-835","DOI":"10.1016\/j.neuron.2019.06.010"},{"issue":"4","key":"2379_CR91","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0896-6273(00)80193-2","volume":"17","author":"RE Gross","year":"1996","unstructured":"Gross RE, Mehler MF, Mabie PC, Zang Z, Santschi L, Kessler JA (1996) Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 17(4):595\u2013606","journal-title":"Neuron"},{"key":"2379_CR92","doi-asserted-by":"crossref","unstructured":"Grubman A, Chew G, Ouyang JF, Sun G, Choo XY, McLean C, ... Polo JM (2019) A single-cell atlas of entorhinal cortex from individuals with Alzheimer\u2019s disease reveals cell-type-specific gene expression regulation.\u00a0Nat Neurosci\u00a022(12):2087-2097","DOI":"10.1038\/s41593-019-0539-4"},{"key":"2379_CR93","doi-asserted-by":"publisher","first-page":"108048","DOI":"10.1016\/j.pharmthera.2021.108048","volume":"234","author":"TR Guilarte","year":"2022","unstructured":"Guilarte TR, Rodichkin AN, McGlothan JL, De La Rocha AMA, Azzam DJ (2022) Imaging neuroinflammation with TSPO: a new perspective on the cellular sources and subcellular localization. Pharmacology & therapeutics 234:108048","journal-title":"Pharmacol Ther"},{"issue":"1","key":"2379_CR94","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.pneurobio.2007.02.009","volume":"83","author":"F Guillemot","year":"2007","unstructured":"Guillemot F (2007) Cell fate specification in the mammalian telencephalon. Progress in neurobiology 83(1):37\u201352","journal-title":"Prog Neurobiol"},{"issue":"4","key":"2379_CR95","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.immuni.2019.03.016","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond TR, Marsh SE, Stevens B (2019) Immune signaling in neurodegeneration. Immunity 50(4):955\u2013974","journal-title":"Immunity"},{"issue":"6","key":"2379_CR96","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S1474-4422(21)00133-2","volume":"20","author":"J Hardy","year":"2021","unstructured":"Hardy J, Salih D (2021) TREM2-mediated activation of microglia breaks link between amyloid and tau. The Lancet Neurology 20(6):416\u2013417","journal-title":"Lancet Neurol"},{"key":"2379_CR97","doi-asserted-by":"crossref","unstructured":"Heckmann BL, Teubner BJ, Tummers B, Boada-Romero E, Harris L, Yang M, ... Green DR (2019) LC3-associated endocytosis facilitates \u03b2-amyloid clearance and mitigates neurodegeneration in murine Alzheimer\u2019s disease.\u00a0Cell\u00a0178(3):536-551","DOI":"10.1016\/j.cell.2019.05.056"},{"issue":"2","key":"2379_CR98","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1046\/j.1471-4159.1998.70020699.x","volume":"70","author":"K Heese","year":"1998","unstructured":"Heese K, Hock C, Otten U (1998) Inflammatory signals induce neurotrophin expression in human microglial cells. Journal of neurochemistry 70(2):699\u2013707","journal-title":"J Neurochem"},{"key":"2379_CR99","doi-asserted-by":"crossref","unstructured":"He F, Ge W, Martinowich K, Becker-Catania S, Coskun V, Zhu W, ... Sun YE (2005) A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis. Nat Neurosci 8(5):616-625","DOI":"10.1038\/nn1440"},{"key":"2379_CR100","doi-asserted-by":"crossref","unstructured":"Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, ... Kummer MP (2015) Neuroinflammation in Alzheimer\u2019s disease.\u00a0Lancet Neurol\u00a014(4):388-405","DOI":"10.1016\/S1474-4422(15)70016-5"},{"key":"2379_CR101","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1056\/NEJMc1813435","volume":"380","author":"D Henley","year":"2019","unstructured":"Henley D, Raghavan N, Sperling R, Aisen P, Raman R, Romano G (2019) Preliminary results of a trial of atabecestat in preclinical Alzheimer\u2019s disease. N. Engl. J. Med. 380:1483\u20131485","journal-title":"N Engl J Med"},{"issue":"6","key":"2379_CR102","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner FL, Ransohoff RM, Becher B (2015) Immune attack: the role of inflammation in Alzheimer disease. Nature Reviews Neuroscience 16(6):358\u2013372","journal-title":"Nat Rev Neurosci"},{"key":"2379_CR103","unstructured":"Hoffmann-La Roche LF (2019) Roche to discontinue phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer\u2019s disease (AD)-other company programmes in AD continue [Press Release]"},{"key":"2379_CR104","doi-asserted-by":"crossref","unstructured":"Holtzman DM, Bales KR, Tenkova T, Fagan AM, Parsadanian M, Sartorius LJ, ... Paul SM (2000) Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease.\u00a0Proc Nat Aca Sci 97(6):2892-2897","DOI":"10.1073\/pnas.050004797"},{"key":"2379_CR105","doi-asserted-by":"crossref","unstructured":"Hong S, Beja-Glasser VF, Nfonoyim BM, Frouin A, Li S, Ramakrishnan S, ... Stevens B (2016) Complement and microglia mediate early synapse loss in Alzheimer mouse models.\u00a0Science\u00a0352(6286):712-716","DOI":"10.1126\/science.aad8373"},{"key":"2379_CR106","doi-asserted-by":"crossref","unstructured":"Huang Y, Happonen KE, Burrola PG, O\u2019Connor C, Hah N, Huang L, ... Lemke G (2021) Microglia use TAM receptors to detect and engulf amyloid \u03b2 plaques.\u00a0Nat Immunol\u00a022(5):586-594","DOI":"10.1038\/s41590-021-00913-5"},{"issue":"5","key":"2379_CR107","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41593-018-0121-5","volume":"21","author":"EG Hughes","year":"2018","unstructured":"Hughes EG, Orthmann-Murphy JL, Langseth AJ, Bergles DE (2018) Myelin remodeling through experience-dependent oligodendrogenesis in the adult somatosensory cortex. Nature neuroscience 21(5):696\u2013706","journal-title":"Nat Neurosci"},{"key":"2379_CR108","doi-asserted-by":"crossref","unstructured":"Hull M, Sadowsky C, Arai H, Le Prince Leterme G, Holstein A, Booth K, ... Michael Ryan J (2017) Long-Term extensions of randomized vaccination trials of ACC-001 and QS-21 in mild to moderate Alzheimer\u2019s disease.\u00a0Curr Alzheimer Res\u00a014(7):696-708","DOI":"10.2174\/1567205014666170117101537"},{"key":"2379_CR109","doi-asserted-by":"crossref","unstructured":"Huynh TPV, Liao F, Francis CM, Robinson GO, Serrano JR, Jiang H, ... Holtzman DM (2017) Age-dependent effects of ApoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis. Neuron 96(5):1013-1023","DOI":"10.1016\/j.neuron.2017.11.014"},{"key":"2379_CR110","doi-asserted-by":"crossref","unstructured":"Ishii A, Pathoulas JA, MoustafaFathy Omar O, Ge Y, Yao AY, Pantalena T, ... Hu X (2024) Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u2019s disease.\u00a0Molecular Neurodegeneration\u00a019(1):83","DOI":"10.1186\/s13024-024-00759-z"},{"key":"2379_CR111","doi-asserted-by":"crossref","unstructured":"Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, ... Heneka MT (2019) NLRP3 inflammasome activation drives tau pathology.\u00a0Nature\u00a0575(7784):669-673","DOI":"10.1038\/s41586-019-1769-z"},{"key":"2379_CR112","unstructured":"ISRCTN (2015) A study comparing the safety and effects of a new compound, ACI-35 with placebo in patients with mild to moderate Alzheimer\u2019s disease [WWW Document], Accessed 5.3.20.\u00a0http:\/\/www.isrctn.com\/ISRCTN13033912"},{"issue":"1","key":"2379_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0169-328X(98)00040-0","volume":"57","author":"D Ito","year":"1998","unstructured":"Ito D, Imai Y, Ohsawa K, Nakajima K, Fukuuchi Y, Kohsaka S (1998) Microglia-specific localisation of a novel calcium binding protein, Iba1. Molecular brain research 57(1):1\u20139","journal-title":"Mol Brain Res"},{"key":"2379_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0197-5","volume":"12","author":"TR Jay","year":"2017","unstructured":"Jay TR, von Saucken VE, Landreth GE (2017) TREM2 in neurodegenerative diseases. Molecular neurodegeneration 12:1\u201333","journal-title":"Mol Neurodegener"},{"key":"2379_CR115","doi-asserted-by":"crossref","unstructured":"Jehle AW, Gardai SJ, Li S, Linsel-Nitschke P, Morimoto K, Janssen WJ, ... Tall AR (2006) ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages.\u00a0J Cell Biol\u00a0174(4):547-556","DOI":"10.1083\/jcb.200601030"},{"key":"2379_CR116","doi-asserted-by":"publisher","first-page":"179","DOI":"10.14283\/jpad.2019.18","volume":"6","author":"F Jessen","year":"2019","unstructured":"Jessen F (2019) Combination therapy for Alzheimer\u2019s disease\u2014the next step. The Journal of Prevention of Alzheimer\u2019s Disease 6:179\u2013179","journal-title":"J Prevent Alzheimer's Dis"},{"key":"2379_CR117","doi-asserted-by":"crossref","unstructured":"Jin SC, Benitez BA, Karch CM, Cooper B, Skorupa T, Carrell D, ... Cruchaga C (2014) Coding variants in TREM2 increase risk for Alzheimer\u2019s disease.\u00a0Hum Mol Gen\u00a023(21):5838-5846","DOI":"10.1093\/hmg\/ddu277"},{"issue":"6239","key":"2379_CR118","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/341226a0","volume":"341","author":"CL Joachim","year":"1989","unstructured":"Joachim CL, Mori H, Selkoe DJ (1989) Amyloid \u03b2-protein deposition in tissues other than brain in Alzheimer\u2019s disease. Nature 341(6239):226\u2013230","journal-title":"Nature"},{"key":"2379_CR119","doi-asserted-by":"crossref","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, ... Stefansson K (2013) Variant of TREM2 associated with the risk of Alzheimer\u2019s disease.\u00a0New Engl J Med\u00a0368(2):107-116","DOI":"10.1056\/NEJMoa1211103"},{"key":"2379_CR120","doi-asserted-by":"crossref","unstructured":"Jorda A, Campos-Campos J, Iradi A, Aldasoro M, Aldasoro C, Vila JM, Valles SL (2020) The role of chemokines in Alzheimer\u2019s disease.\u00a0Endocr Metab Immune Disord Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders)\u00a020(9):1383-1390","DOI":"10.2174\/1871530320666200131110744"},{"issue":"20","key":"2379_CR121","doi-asserted-by":"publisher","first-page":"4159","DOI":"10.1242\/jcs.00718","volume":"116","author":"H Kajiho","year":"2003","unstructured":"Kajiho H, Saito K, Tsujita K, Kontani K, Araki Y, Kurosu H, Katada T (2003) RIN3: a novel Rab5 GEF interacting with amphiphysin II involved in the early endocytic pathway. Journal of cell science 116(20):4159\u20134168","journal-title":"J Cell Sci"},{"key":"2379_CR122","doi-asserted-by":"crossref","unstructured":"Kajiho H, Sakurai K, Minoda T, Yoshikawa M, Nakagawa S, Fukushima S, ... Katada T (2011) Characterization of RIN3 as a guanine nucleotide exchange factor for the Rab5 subfamily GTPase Rab31.\u00a0J Biol Chem\u00a0286(27):24364-24373","DOI":"10.1074\/jbc.M110.172445"},{"issue":"6","key":"2379_CR123","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1080\/10715760802159057","volume":"42","author":"YG Kaminsky","year":"2008","unstructured":"Kaminsky YG, Kosenko EA (2008) Effects of amyloid-beta peptides on hydrogen peroxide-metabolizing enzymes in rat brain in vivo. Free Radical Research 42(6):564\u2013573","journal-title":"Free Radical Res"},{"key":"2379_CR124","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00018-013-1435-9","volume":"71","author":"R Kanski","year":"2014","unstructured":"Kanski R, van Strien ME, van Tijn P, Hol EM (2014) A star is born: new insights into the mechanism of astrogenesis. Cellular and Molecular Life Sciences 71:433\u2013447","journal-title":"Cell Mol Life Sci"},{"key":"2379_CR125","doi-asserted-by":"crossref","unstructured":"Karch CM, Ezerskiy LA, Bertelsen S, Alzheimer\u2019s Disease Genetics Consortium (ADGC), Goate AM (2016) Alzheimer\u2019s disease risk polymorphisms regulate gene expression in the ZCWPW1 and the CELF1 loci. PloS one 11(2):e0148717","DOI":"10.1371\/journal.pone.0148717"},{"key":"2379_CR126","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s10787-019-00599-5","volume":"27","author":"D Kaur","year":"2019","unstructured":"Kaur D, Sharma V, Deshmukh R (2019) Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer\u2019s disease. Inflammopharmacology 27:663\u2013677. https:\/\/doi.org\/10.1007\/s10787-019-00599-5","journal-title":"Inflammopharmacology"},{"key":"2379_CR127","doi-asserted-by":"crossref","unstructured":"Kenigsbuch M, Bost P, Halevi S, Chang Y, Chen S, Ma Q, ... Amit I (2022) A shared disease-associated oligodendrocyte signature among multiple CNS pathologies.\u00a0Nat Neurosci\u00a025(7):876-886","DOI":"10.1038\/s41593-022-01104-7"},{"key":"2379_CR128","doi-asserted-by":"crossref","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, ... Amit I (2017) A unique microglia type associated with restricting development of Alzheimer\u2019s disease.\u00a0Cell\u00a0169(7):1276-1290","DOI":"10.1016\/j.cell.2017.05.018"},{"key":"2379_CR129","doi-asserted-by":"crossref","unstructured":"Ketter N, Liu E, Di J, Honig LS, Lu M, Novak G, ... Brashear HR (2016) A randomized, double-blind, phase 2 study of the effects of the vaccine vanutide cridificar with QS-21 adjuvant on immunogenicity, safety and amyloid imaging in patients with mild to moderate Alzheimer\u2019s disease.\u00a0J Prevent Alzheimers Dis\u00a03(4):192-201","DOI":"10.14283\/jpad.2016.118"},{"key":"2379_CR130","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.neuroscience.2017.02.011","volume":"348","author":"JG Kilian","year":"2017","unstructured":"Kilian JG, Hsu HW, Mata K, Wolf FW, Kitazawa M (2017) Astrocyte transport of glutamate and neuronal activity reciprocally modulate tau pathology in Drosophila. Neuroscience 348:191\u2013200","journal-title":"Neuroscience"},{"issue":"2","key":"2379_CR131","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/(SICI)1097-4547(19970715)49:2<229::AID-JNR11>3.0.CO;2-W","volume":"49","author":"A Klegeris","year":"1997","unstructured":"Klegeris A, McGeer PL (1997) \u03b2-Amyloid protein enhances macrophage production of oxygen free radicals and glutamate. Journal of neuroscience research 49(2):229\u2013235","journal-title":"J Neurosci Res"},{"issue":"2","key":"2379_CR132","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1006\/bbrc.1994.1326","volume":"199","author":"A Klegeris","year":"1994","unstructured":"Klegeris A, Walker DG, McGeer PL (1994) Activation of macrophages by Alzheimer \u03b2 amyloid peptide. Biochemical and biophysical research communications 199(2):984\u2013991","journal-title":"Biochem Biophys Res Commun"},{"key":"2379_CR133","doi-asserted-by":"publisher","unstructured":"Kleinberger G, Dube U, Blennow K, Karch CM, Svensson J, Fernandez MV, ... Bradley J (2018) The MS4A gene cluster is a key regulator of soluble TREM2 and Alzheimer disease risk.\u00a0Sci Transl Med\u00a011.\u00a0https:\/\/doi.org\/10.1126\/scitranslmed.aau2291","DOI":"10.1126\/scitranslmed.aau2291"},{"key":"2379_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-015-0385-6","volume":"12","author":"K Kucharova","year":"2015","unstructured":"Kucharova K, Stallcup WB (2015) NG2-proteoglycan-dependent contributions of oligodendrocyte progenitors and myeloid cells to myelin damage and repair. Journal of Neuroinflammation 12:1\u201317","journal-title":"J Neuroinflammation"},{"issue":"5918","key":"2379_CR135","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1126\/science.1169096","volume":"323","author":"KV Kuchibhotla","year":"2009","unstructured":"Kuchibhotla KV, Lattarulo CR, Hyman BT, Bacskai BJ (2009) Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science 323(5918):1211\u20131215","journal-title":"Science"},{"key":"2379_CR136","doi-asserted-by":"crossref","unstructured":"Kulijewicz-Nawrot M, Sykov\u00e1 E, Chv\u00e1tal A, Verkhratsky A, Rodr\u00edguez JJ (2013) Astrocytes and glutamate homoeostasis in Alzheimer\u2019s disease: a decrease in glutamine synthetase, but not in glutamate transporter-1, in the prefrontal cortex. ASN Neuro 5(4):AN20130017","DOI":"10.1042\/AN20130017"},{"key":"2379_CR137","doi-asserted-by":"crossref","unstructured":"Lace G, Ince PG, Brayne C, Savva GM, Matthews FE, De Silva R, ... Wharton SB (2012) Mesial temporal astrocyte tau pathology in the MRC-CFAS ageing brain cohort.\u00a0Dement Geriatr Cogn Disord\u00a034(1):15-24","DOI":"10.1159\/000341581"},{"key":"2379_CR138","doi-asserted-by":"crossref","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, ... Foroud TM (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease.\u00a0Nat Gen\u00a045(12):1452-1458","DOI":"10.1038\/ng.2802"},{"key":"2379_CR139","doi-asserted-by":"crossref","unstructured":"Landen JW, Cohen S, Billing Jr CB, Cronenberger C, Styren S, Burstein AH, ... Binneman B (2017) Multiple\u2010dose ponezumab for mild\u2010to\u2010moderate Alzheimer\u2019s disease: safety and efficacy.\u00a0Alzheimers Dement: Transla Res Clin Intervent\u00a03(3):339-347","DOI":"10.1016\/j.trci.2017.04.003"},{"key":"2379_CR140","doi-asserted-by":"crossref","unstructured":"Lee JT, Xu J, Lee JM, Ku G, Han X, Yang DI, ... Hsu CY (2004) Amyloid-\u03b2 peptide induces oligodendrocyte death by activating the neutral sphingomyelinase\u2013ceramide pathway.\u00a0J Cell Biol\u00a0164(1):123-131","DOI":"10.1083\/jcb.200307017"},{"key":"2379_CR141","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","volume":"17","author":"F Leng","year":"2021","unstructured":"Leng F, Edison P (2021) Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here? Nature Reviews Neurology 17:157\u2013172. https:\/\/doi.org\/10.1038\/s41582-020-00435-y","journal-title":"Nat Rev Neurol"},{"key":"2379_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0192-x","volume":"12","author":"CE Leyns","year":"2017","unstructured":"Leyns CE, Holtzman DM (2017) Glial contributions to neurodegeneration in tauopathies. Molecular neurodegeneration 12:1\u201316","journal-title":"Mol Neurodegener"},{"key":"2379_CR143","doi-asserted-by":"crossref","unstructured":"Lian H, Yang L, Cole A, Sun L, Chiang ACA, Fowler SW, ... Zheng H (2015) NF\u03baB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer\u2019s disease. Neuron 85(1):101-115","DOI":"10.1016\/j.neuron.2014.11.018"},{"key":"2379_CR144","doi-asserted-by":"crossref","unstructured":"Lin YT, Seo J, Gao F, Feldman HM, Wen HL, Penney J, ...\u00a0 Tsai LH (2018) ApoE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types.\u00a0Neuron 98(6):1141-1154","DOI":"10.1016\/j.neuron.2018.05.008"},{"key":"2379_CR145","doi-asserted-by":"crossref","unstructured":"Lin PB, Tsai AP, Soni D, Lee\u2010Gosselin A, Moutinho M, Puntambekar SS, ... Oblak AL (2023) INPP5D deficiency attenuates amyloid pathology in a mouse model of Alzheimer\u2019s disease.\u00a0Alzheimers Dement\u00a019(6):2528-2537","DOI":"10.1002\/alz.12849"},{"issue":"1","key":"2379_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/jpet.102.035048","volume":"304","author":"BIN Liu","year":"2003","unstructured":"Liu BIN, Hong JS (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. Journal of Pharmacology and Experimental Therapeutics 304(1):1\u20137","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"2379_CR147","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"CC Liu","year":"2017","unstructured":"Liu CC, Zhao N, Fu Y, Wang N, Linares C, Tsai CW, Bu G (2017) ApoE4 accelerates early seeding of amyloid pathology. Neuron 96(5):1024\u20131032","journal-title":"Neuron"},{"key":"2379_CR148","doi-asserted-by":"crossref","unstructured":"Liu W, Taso O, Wang R, Bayram S, Graham AC, Garcia-Reitboeck P, ... Salih DA (2020) Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions.\u00a0Hum Mol Gen\u00a029(19):3224-3248","DOI":"10.1093\/hmg\/ddaa209"},{"key":"2379_CR149","doi-asserted-by":"crossref","unstructured":"Liu X, Zhan Z, Li D, Xu L, Ma F, Zhang P, ... Cao X (2011) Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk.\u00a0Nat Immunol\u00a012(5):416-424","DOI":"10.1038\/ni.2015"},{"key":"2379_CR150","doi-asserted-by":"crossref","unstructured":"Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, ... Mukadam N (2017) Dementia prevention, intervention, and care.\u00a0The lancet\u00a0390(10113):2673-2734","DOI":"10.1016\/S0140-6736(17)31363-6"},{"key":"2379_CR151","doi-asserted-by":"crossref","unstructured":"Lynch J, Guo L, Gelebart P, Chilibeck K, Xu J, Molkentin JD, ... Michalak M (2005) Calreticulin signals upstream of calcineurin and MEF2C in a critical Ca2+-dependent signaling cascade.\u00a0J Cell Biol\u00a0170(1):37-47","DOI":"10.1083\/jcb.200412156"},{"key":"2379_CR152","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"MBS Lopes","year":"2017","unstructured":"Lopes MBS (2017) The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta neuropathologica 134:521\u2013535","journal-title":"Acta Neuropathol"},{"key":"2379_CR153","doi-asserted-by":"crossref","unstructured":"Lopez CL, Tariot PN, Caputo A, Langbaum JB, Liu F, Riviere ME, ... Reiman EM (2019) The Alzheimer\u2019s Prevention Initiative Generation Program: study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer\u2019s disease.\u00a0Alzheimers Dement Transl Res Clin Interv\u00a05:216-227","DOI":"10.1016\/j.trci.2019.02.005"},{"key":"2379_CR154","doi-asserted-by":"publisher","unstructured":"Lopez-Rodriguez AB, Hennessy E, Murray CL, Nazmi A, Delaney HJ, Healy D, ... Cunningham C (2021) Acute systemic inflammation exacerbates neuroinflammation in Alzheimer\u2019s disease: IL\u20101\u03b2 drives amplified responses in primed astrocytes and neuronal network dysfunction. Alzheimers Dement 17(10):1735\u20131755. https:\/\/doi.org\/10.1002\/alz.12338","DOI":"10.1002\/alz.12338"},{"issue":"1","key":"2379_CR155","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0165-5728(96)00111-2","volume":"67","author":"D Lorton","year":"1996","unstructured":"Lorton D, Kocsis JM, King L, Madden K, Brunden KR (1996) Beta-amyloid induces increased release of interleukin-1\u03b2 from lipopolysaccharide-activated human monocytes. Journal of Neuroimmunology 67(1):21\u201329. https:\/\/doi.org\/10.1016\/S0165-5728(96)00111-2","journal-title":"J Neuroimmunol"},{"key":"2379_CR156","doi-asserted-by":"crossref","unstructured":"Lozupone M, Solfrizzi V, D\u2019Urso F, Di Gioia I, Sardone R, Dibello V, ... Panza F (2020) Anti-amyloid-\u03b2 protein agents for the treatment of Alzheimer\u2019s disease: an update on emerging drugs.\u00a0Exp Opin Emerg Drugs\u00a025(3):319-335","DOI":"10.1080\/14728214.2020.1808621"},{"issue":"24","key":"2379_CR157","doi-asserted-by":"publisher","first-page":"7743","DOI":"10.1523\/JNEUROSCI.0341-09.2009","volume":"29","author":"SE Lutz","year":"2009","unstructured":"Lutz SE, Zhao Y, Gulinello M, Lee SC, Raine CS, Brosnan CF (2009) Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation. Journal of Neuroscience 29(24):7743\u20137752","journal-title":"J Neurosci"},{"key":"2379_CR158","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neubiorev.2017.02.001","volume":"75","author":"M Mamelak","year":"2017","unstructured":"Mamelak M (2017) Energy and the Alzheimer brain. Neuroscience & Biobehavioral Reviews 75:297\u2013313","journal-title":"Neurosci Biobehav Rev"},{"issue":"9","key":"2379_CR159","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/NEN.0000000000000106","volume":"73","author":"K Markoullis","year":"2014","unstructured":"Markoullis K, Sargiannidou I, Schiza N, Roncaroli F, Reynolds R, Kleopa KA (2014) Oligodendrocyte gap junction loss and disconnection from reactive astrocytes in multiple sclerosis gray matter. Journal of Neuropathology & Experimental Neurology 73(9):865\u2013879","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"2379_CR160","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41380-022-01631-6","volume":"28","author":"A Mary","year":"2023","unstructured":"Mary A, Eysert F, Checler F, Chami M (2023) Mitophagy in Alzheimer\u2019s disease: molecular defects and therapeutic approaches. Molecular psychiatry 28(1):202\u2013216","journal-title":"Mol Psychiatry"},{"issue":"4\u20135","key":"2379_CR161","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0143-4160(03)00128-3","volume":"34","author":"MP Mattson","year":"2003","unstructured":"Mattson MP, Chan SL (2003) Neuronal and glial calcium signaling in Alzheimer\u2019s disease. Cell calcium 34(4\u20135):385\u2013397","journal-title":"Cell Calcium"},{"key":"2379_CR162","doi-asserted-by":"crossref","unstructured":"McKenzie IA, Ohayon D, Li H, Paes de Faria J, Emery B, Tohyama K, Richardson WD (2014) Motor skill learning requires active central myelination. Science\u00a0346(6207):318-322","DOI":"10.1126\/science.1254960"},{"key":"2379_CR163","doi-asserted-by":"crossref","unstructured":"McKenzie AT, Moyon S, Wang M, Katsyv I, Song WM, Zhou X, ... Zhang B (2017) Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer\u2019s disease.\u00a0Mol Neurodegen\u00a012:1-20","DOI":"10.1186\/s13024-017-0219-3"},{"key":"2379_CR164","doi-asserted-by":"crossref","unstructured":"Meda L, Cassatella MA, Szendrei GI, Otvos Jr L, Baron P, Villalba M, ... Rossi F (1995) Activation of microglial cells by \u03b2-amyloid protein and interferon-\u03b3. Nature\u00a0374(6523):647-650","DOI":"10.1038\/374647a0"},{"issue":"3","key":"2379_CR165","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1096\/fj.05-4297fje","volume":"20","author":"W M\u00eame","year":"2006","unstructured":"M\u00eame W, Calvo CF, Froger N, Ezan P, Amigou E, Koulakoff A, Giaume C (2006) Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by beta-amyloid. FASEB Journal 20(3):494\u2013496. https:\/\/doi.org\/10.1096\/fj.05-4297fje","journal-title":"FASEB J"},{"issue":"1\u20132","key":"2379_CR166","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(02)00216-6","volume":"202","author":"A Minagar","year":"2002","unstructured":"Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C (2002) The role of macrophage\/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. Journal of the Neurological Sciences 202(1\u20132):13\u201323. https:\/\/doi.org\/10.1016\/S0022-510X(02)00216-6","journal-title":"J Neurol Sci"},{"key":"2379_CR167","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00401-010-0657-2","volume":"119","author":"S Mitew","year":"2010","unstructured":"Mitew S, Kirkcaldie MT, Halliday GM, Shepherd CE, Vickers JC, Dickson TC (2010) Focal demyelination in Alzheimer\u2019s disease and transgenic mouse models. Acta neuropathologica 119:567\u2013577","journal-title":"Acta Neuropathol"},{"issue":"8","key":"2379_CR168","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1002\/glia.22836","volume":"63","author":"AV Molofsky","year":"2015","unstructured":"Molofsky AV, Deneen B (2015) Astrocyte development: a guide for the perplexed. Glia 63(8):1320\u20131329","journal-title":"Glia"},{"issue":"3","key":"2379_CR169","doi-asserted-by":"publisher","first-page":"103487","DOI":"10.1016\/j.drudis.2023.103487","volume":"28","author":"KB Moore","year":"2023","unstructured":"Moore KB, Hung TJ, Fortin JS (2023) Hyperphosphorylated tau (p-tau) and drug discovery in the context of Alzheimer\u2019s disease and related tauopathies. Drug discovery today 28(3):103487","journal-title":"Drug Discov Today"},{"key":"2379_CR170","doi-asserted-by":"crossref","unstructured":"Morimoto BH, Schmechel D, Hirman J, Blackwell A, Keith J, Gold M, AL-108-211 Study Investigators (2013) A double-blind, placebo-controlled, ascending-dose, randomized study to evaluate the safety, tolerability and effects on cognition of AL-108 after 12 weeks of intranasal administration in subjects with mild cognitive impairment.\u00a0Dement Geriatr Cogn Disord\u00a035(5\u20136):325\u2013339","DOI":"10.1159\/000348347"},{"issue":"19","key":"2379_CR171","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.3390\/ijms20194661","volume":"20","author":"B Mroczko","year":"2019","unstructured":"Mroczko B, Groblewska M, Litman-Zawadzka A (2019) The role of protein misfolding and tau oligomers (TauOs) in Alzheimer\u2019s disease (AD). International journal of molecular sciences 20(19):4661","journal-title":"Int J Mol Sci"},{"key":"2379_CR172","doi-asserted-by":"crossref","unstructured":"Montagne A, Nation DA, Sagare AP, Barisano G, Sweeney MD, Chakhoyan A, ... Zlokovic BV (2020) ApoE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline. Nature 581(7806):71-76","DOI":"10.1038\/s41586-020-2247-3"},{"key":"2379_CR173","doi-asserted-by":"crossref","unstructured":"Moutinho M, Coronel I, Tsai AP, Di Prisco GV, Pennington T, Atwood BK, ... Landreth GE (2023) TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation.\u00a0Genome Med\u00a015(1):11","DOI":"10.1186\/s13073-023-01160-z"},{"key":"2379_CR174","doi-asserted-by":"crossref","unstructured":"Murray ME, Przybelski SA, Lesnick TG, Liesinger AM, Spychalla A, Zhang B, ... Kantarci K (2014) Early Alzheimer\u2019s disease neuropathology detected by proton MR spectroscopy.\u00a0J Neurosci\u00a034(49):16247-16255","DOI":"10.1523\/JNEUROSCI.2027-14.2014"},{"key":"2379_CR175","doi-asserted-by":"crossref","unstructured":"Naeem A, Prakash R, Kumari N, Khan MA, Khan AQ, Uddin S, ... Raza SS (2024) MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer's disease.\u00a0Brain Behav Immun\u00a0116:70-84","DOI":"10.1016\/j.bbi.2023.11.031"},{"issue":"3","key":"2379_CR176","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nrd3366","volume":"10","author":"AH Nagahara","year":"2011","unstructured":"Nagahara AH, Tuszynski MH (2011) Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nature reviews Drug discovery 10(3):209\u2013219","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2379_CR177","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0014-5793(99)00997-7","volume":"457","author":"K Nakashima","year":"1999","unstructured":"Nakashima K, Yanagisawa M, Arakawa H, Taga T (1999) Astrocyte differentiation mediated by LIF in cooperation with BMP2. FEBS letters 457(1):43\u201346","journal-title":"FEBS Lett"},{"key":"2379_CR178","unstructured":"Neuroscience U (2019)\u00a0United neuroscience announces positive top-line results from phase 2a clinical study of UB-311 vaccine in patients with Alzheimer\u2019s disease"},{"key":"2379_CR179","doi-asserted-by":"crossref","unstructured":"Nguyen AT, Wang K, Hu G, Wang X, Miao Z, Azevedo JA, ... Lee EB (2020) ApoE and TREM2 regulate amyloid-responsive microglia in Alzheimer\u2019s disease.\u00a0Acta\u00a0Neuropathol\u00a0140:477-493","DOI":"10.1007\/s00401-020-02200-3"},{"key":"2379_CR180","doi-asserted-by":"crossref","unstructured":"Nielsen HM, Ek D, Avdic U, Orbj\u00f6rn C, Hansson O, Netherlands Brain Bank i. huitinga@ nin. knaw. nl, ...\u00a0 Wennstr\u00f6m M (2013) NG2 cells, a new trail for Alzheimer\u2019s disease mechanisms?.\u00a0Acta Neuropathol Commun\u00a01:1-13","DOI":"10.1186\/2051-5960-1-7"},{"issue":"5","key":"2379_CR181","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/jcbfm.2012.212","volume":"33","author":"LH Nilsen","year":"2013","unstructured":"Nilsen LH, Rae C, Ittner LM, G\u00f6tz J, Sonnewald U (2013) Glutamate metabolism is impaired in transgenic mice with tau hyperphosphorylation. Journal of Cerebral Blood Flow & Metabolism 33(5):684\u2013691","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"2379_CR182","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1083\/jcb.114.2.359","volume":"114","author":"A Nishiyama","year":"1991","unstructured":"Nishiyama A, Dahlin KJ, Prince JT, Johnstone SR, Stallcup WB (1991) The primary structure of NG2, a novel membrane-spanning proteoglycan. The Journal of cell biology 114(2):359\u2013371","journal-title":"J Cell Biol"},{"issue":"1","key":"2379_CR183","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrn2495","volume":"10","author":"A Nishiyama","year":"2009","unstructured":"Nishiyama A, Komitova M, Suzuki R, Zhu X (2009) Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nature Reviews Neuroscience 10(1):9\u201322","journal-title":"Nat Rev Neurosci"},{"key":"2379_CR184","doi-asserted-by":"publisher","unstructured":"Nutma E, Ceyz\u00e9riat K, Amor S, Tsartsalis S, Millet P, Owen DR, Guillemin GJ, Koenders MI, Tournier BB (2022) Cellular sources of TSPO expression in healthy and diseased brain. Eur J Nucl Med Mol Imaging 49(1):146\u2013163. https:\/\/doi.org\/10.1007\/s00259-020-05166-2","DOI":"10.1007\/s00259-020-05166-2"},{"issue":"19","key":"2379_CR185","doi-asserted-by":"publisher","first-page":"10740","DOI":"10.1073\/pnas.1834348100","volume":"100","author":"M Okigaki","year":"2003","unstructured":"Okigaki M, Davis C, Falasca M, Harroch S, Felsenfeld DP, Sheetz MP, Schlessinger J (2003) Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration. Proceedings of the National Academy of Sciences 100(19):10740\u201310745","journal-title":"Proc Natl Acad Sci"},{"key":"2379_CR186","doi-asserted-by":"crossref","unstructured":"Olive C, Ibanez L, Farias FHG, Wang F, Budde JP, Norton JB, ... Fernandez MV (2020) Examination of the effect of rare variants in TREM2, ABI3, and PLCG2 in LOAD through multiple phenotypes.\u00a0J Alzheimer's Dis\u00a077(4):1469-1482","DOI":"10.3233\/JAD-200019"},{"key":"2379_CR187","doi-asserted-by":"crossref","unstructured":"Orgogozo JM, Gilman S, Dartigues JF, Laurent B, Puel M, Kirby LC, ... Hock C (2003) Subacute meningoencephalitis in a subset of patients with AD after A\u03b242 immunization.\u00a0Neurology\u00a061(1):46-54","DOI":"10.1212\/01.WNL.0000073623.84147.A8"},{"key":"2379_CR188","doi-asserted-by":"crossref","unstructured":"Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, ... Haass C (2019) Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat Neurosci 22(2):191-204","DOI":"10.1038\/s41593-018-0296-9"},{"key":"2379_CR189","doi-asserted-by":"crossref","unstructured":"Penke B, Sz\u0171cs M, Bog\u00e1r F (2020) Oligomerization and conformational change turn monomeric \u03b2-amyloid and tau proteins toxic: their role in Alzheimer\u2019s pathogenesis. Molecules\u00a025(7):1659","DOI":"10.3390\/molecules25071659"},{"key":"2379_CR190","doi-asserted-by":"crossref","unstructured":"Piccio L, Buonsanti C, Cella M, Tassi I, Schmidt RE, Fenoglio C, ... Cross AH (2008) Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation.\u00a0Brain\u00a031(11):3081-3091","DOI":"10.1093\/brain\/awn217"},{"key":"2379_CR191","doi-asserted-by":"crossref","unstructured":"Pomilio C, Gorojod RM, Riudavets M, Vinuesa A, Presa J, Gregosa A, ... Saravia F (2020) Microglial autophagy is impaired by prolonged exposure to \u03b2-amyloid peptides: evidence from experimental models and Alzheimer\u2019s disease patients.\u00a0Geroscience\u00a042:613-632","DOI":"10.1007\/s11357-020-00161-9"},{"key":"2379_CR192","doi-asserted-by":"crossref","unstructured":"Parbo P, Ismail R, Hansen KV, Amidi A, M\u00e5rup FH, Gottrup H, ... Brooks DJ (2017) Brain inflammation accompanies amyloid in the majority of mild cognitive impairment cases due to Alzheimer\u2019s disease.\u00a0Brain\u00a0140(7):2002-2011","DOI":"10.1093\/brain\/awx120"},{"issue":"6","key":"2379_CR193","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/pharmaceutics14061117","volume":"14","author":"T Pardo-Moreno","year":"2022","unstructured":"Pardo-Moreno T, Gonz\u00e1lez-Acedo A, Rivas-Dom\u00ednguez A, Garc\u00eda-Morales V, Garc\u00eda-Cozar FJ, Ramos-Rodr\u00edguez JJ, Melguizo-Rodr\u00edguez L (2022) Therapeutic approach to Alzheimer\u2019s disease: current treatments and new perspectives. Pharmaceutics 14(6):1117","journal-title":"Pharmaceutics"},{"key":"2379_CR194","doi-asserted-by":"crossref","unstructured":"Passamonti L, Tsvetanov KA, Jones PS, Bevan-Jones WR, Arnold R, Borchert RJ, ... Rowe JB (2019) Neuroinflammation and functional connectivity in Alzheimer\u2019s disease: interactive influences on cognitive performance.\u00a0J\u00a0 Neurosci\u00a039(36):7218-7226","DOI":"10.1523\/JNEUROSCI.2574-18.2019"},{"key":"2379_CR195","unstructured":"Phase II (2019) Axon announces positive results from phase II ADAMANT trial for AADvac1 in Alzheimer\u2019s disease"},{"key":"2379_CR196","doi-asserted-by":"publisher","first-page":"105010","DOI":"10.1016\/j.nbd.2020.105010","volume":"144","author":"SS Plotkin","year":"2020","unstructured":"Plotkin SS, Cashman NR (2020) Passive immunotherapies targeting A\u03b2 and tau in Alzheimer\u2019s disease. Neurobiology of Disease 144:105010","journal-title":"Neurobiol Dis"},{"key":"2379_CR197","doi-asserted-by":"crossref","unstructured":"Pluschke G, Vanek M, Evans A, Dittmar T, Schmid P, Itin P, ... Reisfeld RA (1996) Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan.\u00a0Proc Nat Acad Sci\u00a093(18):9710-9715","DOI":"10.1073\/pnas.93.18.9710"},{"key":"2379_CR198","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00109-014-1138-1","volume":"92","author":"I Prokic","year":"2014","unstructured":"Prokic I, Cowling BS, Laporte J (2014) Amphiphysin 2 (BIN1) in physiology and diseases. Journal of molecular medicine 92:453\u2013463","journal-title":"J Mol Med"},{"issue":"1","key":"2379_CR199","first-page":"191863","volume":"2014","author":"J Provias","year":"2014","unstructured":"Provias J, Jeynes B (2014) The role of the blood-brain barrier in the pathogenesis of senile plaques in Alzheimer\u2019s disease. International journal of alzheimer\u2019s disease 2014(1):191863","journal-title":"Int J Alzheimers Dis"},{"key":"2379_CR200","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3389\/fnins.2014.00074","volume":"8","author":"S Qin","year":"2014","unstructured":"Qin S, Niu W, Iqbal N, Smith DK, Zhang CL (2014) Orphan nuclear receptor TLX regulates astrogenesis by modulating BMP signaling. Frontiers in neuroscience 8:74","journal-title":"Front Neurosci"},{"key":"2379_CR201","doi-asserted-by":"crossref","unstructured":"Ramakrishna K, Nalla LV, Naresh D, Venkateswarlu K, Viswanadh MK, Nalluri BN, Singh SK (2023) WNT-\u03b2 catenin signaling as a potential therapeutic target for neurodegenerative diseases: current status and future perspective.\u00a0Diseases 11(3):89","DOI":"10.3390\/diseases11030089"},{"key":"2379_CR202","doi-asserted-by":"crossref","unstructured":"Reiman EM, Chen K, Liu X, Bandy D, Yu M, Lee W, ... Caselli RJ (2009) Fibrillar amyloid-\u03b2 burden in cognitively normal people at 3 levels of genetic risk for Alzheimer\u2019s disease.\u00a0Proc Nat Acad Sci\u00a0106(16):6820-6825","DOI":"10.1073\/pnas.0900345106"},{"key":"2379_CR203","doi-asserted-by":"crossref","unstructured":"Richetin K, Steullet P, Pachoud M, Perbet R, Parietti E, Maheswaran M, ... D\u00e9glon N (2020) Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer\u2019s disease.\u00a0Nat Neurosci\u00a023(12):1567-1579","DOI":"10.1038\/s41593-020-00728-x"},{"key":"2379_CR204","first-page":"160","volume":"8","author":"M Ries","year":"2016","unstructured":"Ries M, Sastre M (2016) Mechanisms of A\u03b2 clearance and degradation by glial cells. Frontiers in aging neuroscience 8:160","journal-title":"Front Neurosci"},{"key":"2379_CR205","doi-asserted-by":"crossref","unstructured":"Rivers LE, Young KM, Rizzi M, Jamen F, Psachoulia K, Wade A, ... Richardson WD (2008) PDGFRA\/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice.\u00a0Nat Neurosci\u00a011(12):1392-1401","DOI":"10.1038\/nn.2220"},{"key":"2379_CR206","unstructured":"Rogers MB (2019) Picking through the rubble, field tries to salvage BACE inhibitors. In:\u00a0AlzForum. https:\/\/www.alzforum.org\/news\/conference-coverage\/picking-through-rubble-field-tries-salvage-bace-inhibitors. Accessed 20 Dec 2019"},{"issue":"4","key":"2379_CR207","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4067\/S0716-97602005000400011","volume":"38","author":"AD Roth","year":"2005","unstructured":"Roth AD, Ram\u00edrez G, Alarc\u00f3n R, Von Bernhardi R (2005) Oligodendrocytes damage in Alzheimer\u2019s disease: beta amyloid toxicity and inflammation. Biological research 38(4):381\u2013387","journal-title":"Biol Res"},{"key":"2379_CR208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-020-00396-2","volume":"15","author":"Z Ruan","year":"2020","unstructured":"Ruan Z, Delpech JC, Venkatesan Kalavai S, Van Enoo AA, Hu J, Ikezu S, Ikezu T (2020) P2RX7 inhibitor suppresses exosome secretion and disease phenotype in P301S tau transgenic mice. Molecular neurodegeneration 15:1\u201314","journal-title":"Mol Neurodegener"},{"key":"2379_CR209","doi-asserted-by":"crossref","unstructured":"Rupprecht R, Papadopoulos V, Rammes G, Baghai TC, Fan J, Akula N, ... Schumacher M (2010). Translocator protein (18 kDa)(TSPO) as a therapeutic target for neurological and psychiatric disorders.\u00a0Nat Rev Drug\u00a0Discov\u00a09(12):971-988","DOI":"10.1038\/nrd3295"},{"issue":"1","key":"2379_CR210","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13024-022-00576-2","volume":"17","author":"A Salasova","year":"2022","unstructured":"Salasova A, Monti G, Andersen OM, Nykjaer A (2022) Finding memo: versatile interactions of the VPS10p-domain receptors in Alzheimer\u2019s disease. Molecular Neurodegeneration 17(1):74","journal-title":"Mol Neurodegener"},{"issue":"3","key":"2379_CR211","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.neulet.2006.07.045","volume":"412","author":"P Salins","year":"2007","unstructured":"Salins P, Shawesh S, He Y, Dibrov A, Kashour T, Arthur G, Amara F (2007) Lovastatin protects human neurons against A\u03b2-induced toxicity and causes activation of \u03b2-catenin\u2013TCF\/LEF signaling. Neuroscience letters 412(3):211\u2013216","journal-title":"Neurosci Lett"},{"key":"2379_CR212","doi-asserted-by":"crossref","unstructured":"Salloway S, Sperling R, Keren R, Porsteinsson AP, Van Dyck CH, Tariot PN, ... & ELND005-AD201 Investigators (2011) A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease.\u00a0Neurology\u00a077(13):1253-1262","DOI":"10.1212\/WNL.0b013e3182309fa5"},{"issue":"13","key":"2379_CR213","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.2174\/1567205015666180821114813","volume":"15","author":"S Salloway","year":"2018","unstructured":"Salloway S, Marshall GA, Lu M, Brashear HR (2018) Long-term safety and efficacy of bapineuzumab in patients with mild-to-moderate Alzheimer\u2019s disease: a phase 2, open-label extension study. Current Alzheimer Research 15(13):1231\u20131243","journal-title":"Curr Alzheimer Res"},{"key":"2379_CR214","doi-asserted-by":"crossref","unstructured":"Sarkar P, Zaja I, Bienengraeber M, Rarick KR, Terashvili M, Canfield S, ... Harder DR (2014) Epoxyeicosatrienoic acids pretreatment improves amyloid \u03b2-induced mitochondrial dysfunction in cultured rat hippocampal astrocytes.\u00a0Am J Physiol-Heart Circ Physiol 306(4):H475-H484","DOI":"10.1152\/ajpheart.00001.2013"},{"key":"2379_CR215","doi-asserted-by":"crossref","unstructured":"Sayed FA, Telpoukhovskaia M, Kodama L, Li Y, Zhou Y Le D, ... Gan L (2018) Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy.\u00a0Proc Nat Acad Sci\u00a0115(40):10172-10177","DOI":"10.1073\/pnas.1811411115"},{"issue":"9","key":"2379_CR216","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus H, Heneka MT (2017) Microglia in Alzheimer\u2019s disease. Journal of Clinical Investigation 127(9):3240\u20133249. https:\/\/doi.org\/10.1172\/JCI90606","journal-title":"J Clin Investig"},{"key":"2379_CR217","doi-asserted-by":"crossref","unstructured":"Sasmita AO, Depp C, Nazarenko T, Sun T, Siems SB, Ong EC, ... Nave KA (2024) Oligodendrocytes produce amyloid-\u03b2 and contribute to plaque formation alongside neurons in Alzheimer\u2019s disease model mice.\u00a0Nat Neurosci\u00a027(9):1668-1674","DOI":"10.1038\/s41593-024-01730-3"},{"issue":"2\u20133","key":"2379_CR218","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ijdevneu.2005.11.014","volume":"24","author":"M Sastre","year":"2006","unstructured":"Sastre M, Klockgether T, Heneka MT (2006) Contribution of inflammatory processes to Alzheimer\u2019s disease: molecular mechanisms. International Journal of Developmental Neuroscience 24(2\u20133):167\u2013176","journal-title":"Int J Dev Neurosci"},{"key":"2379_CR219","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fncel.2015.00076","volume":"9","author":"C Schitine","year":"2015","unstructured":"Schitine C, Nogaroli L, Costa MR, Hedin-Pereira C (2015) Astrocyte heterogeneity in the brain: from development to disease. Frontiers in cellular neuroscience 9:76","journal-title":"Front Cell Neurosci"},{"issue":"10","key":"2379_CR220","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.15252\/emmm.201707672","volume":"9","author":"K Schlepckow","year":"2017","unstructured":"Schlepckow K, Kleinberger G, Fukumori A, Feederle R, Lichtenthaler SF, Steiner H, Haass C (2017) An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function. EMBO molecular medicine 9(10):1356\u20131365","journal-title":"EMBO Mol Med"},{"key":"2379_CR221","doi-asserted-by":"crossref","unstructured":"Schoch KM, Ezerskiy LA, Morhaus MM, Bannon RN, Sauerbeck AD, Shabsovich M, ... Miller TM (2021) Acute Trem2 reduction triggers increased microglial phagocytosis, slowing amyloid deposition in mice.\u00a0Proc Nat Acad Sci\u00a0118(27):e2100356118","DOI":"10.1073\/pnas.2100356118"},{"issue":"7","key":"2379_CR222","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/NEN.0000000000000084","volume":"73","author":"N Schultz","year":"2014","unstructured":"Schultz N, Nielsen HM, Minthon L, Wennstr\u00f6m M (2014) Involvement of matrix metalloproteinase-9 in amyloid-\u03b2 1\u201342\u2013induced shedding of the pericyte proteoglycan NG2. Journal of Neuropathology & Experimental Neurology 73(7):684\u2013692","journal-title":"J Neuropathol Exp Neurol"},{"key":"2379_CR223","doi-asserted-by":"crossref","unstructured":"Sch\u00fcrmann B, Bermingham DP, Kopeikina KJ, Myczek K, Yoon S, Horan KE, ... Penzes P (2020) A novel role for the late-onset Alzheimer\u2019s disease (LOAD)-associated protein Bin1 in regulating postsynaptic trafficking and glutamatergic signaling.\u00a0Mol Psychiatry\u00a025(9):2000-2016","DOI":"10.1038\/s41380-019-0407-3"},{"key":"2379_CR224","doi-asserted-by":"crossref","unstructured":"Seeburger JL, Holder DJ, Combrinck M, Joachim C, Laterza O, Tanen M, ... Smith AD (2015) Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer\u2019s disease from other dementias and healthy controls in the OPTIMA cohort. J Alzheimers Dis 44(2):525-539","DOI":"10.3233\/JAD-141725"},{"key":"2379_CR225","doi-asserted-by":"crossref","unstructured":"Sekar S, McDonald J. Cuyugan L, Aldrich J, Kurdoglu A, Adkins J, ... Liang, WS (2015) Alzheimer\u2019s disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes.\u00a0Neurobiol Aging 36(2):583-591","DOI":"10.1016\/j.neurobiolaging.2014.09.027"},{"key":"2379_CR226","doi-asserted-by":"crossref","unstructured":"Sekino S, Kashiwagi Y, Kanazawa H, Takada K, Baba T, Sato S, ... Tani K (2015) The NESH\/Abi-3-based WAVE2 complex is functionally distinct from the Abi-1-based WAVE2 complex. Cell Commun Signal 13:1-15","DOI":"10.1186\/s12964-015-0119-5"},{"issue":"6","key":"2379_CR227","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO molecular medicine 8(6):595\u2013608","journal-title":"EMBO Mol Med"},{"issue":"6","key":"2379_CR228","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1097\/NEN.0b013e3182933788","volume":"72","author":"A Serrano-Pozo","year":"2013","unstructured":"Serrano-Pozo A, Muzikansky A, G\u00f3mez-Isla T, Growdon JH, Betensky RA, Frosch MP, Hyman BT (2013) Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease. Journal of Neuropathology & Experimental Neurology 72(6):462\u2013471","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"2379_CR229","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo A, Das S, Hyman BT (2021) APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. The Lancet Neurology 20(1):68\u201380","journal-title":"Lancet Neurol"},{"key":"2379_CR230","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fnagi.2017.00083","volume":"9","author":"SS Shafiei","year":"2017","unstructured":"Shafiei SS, Guerrero-Mu\u00f1oz MJ, Castillo-Carranza DL (2017) Tau oligomers: cytotoxicity, propagation, and mitochondrial damage. Frontiers in aging neuroscience 9:83","journal-title":"Front Aging Neurosci"},{"key":"2379_CR231","doi-asserted-by":"publisher","unstructured":"Sims R, vanderLee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J et al (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat Genet 49:13731384. https:\/\/doi.org\/10.1038\/ng.3916","DOI":"10.1038\/ng.3916"},{"key":"2379_CR232","doi-asserted-by":"crossref","unstructured":"Singh N, Benoit MR, Zhou J, Das B, Davila-Velderrain J, Kellis M, ... Yan R (2022) BACE-1 inhibition facilitates the transition from homeostatic microglia to DAM-1. Sci\u00a0 Adv\u00a08(24):eabo1286","DOI":"10.1126\/sciadv.abo1286"},{"key":"2379_CR233","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s11064-009-0022-9","volume":"34","author":"SD Skaper","year":"2009","unstructured":"Skaper SD, Evans NA, Soden PE, Rosin C, Facci L, Richardson JC (2009) Oligodendrocytes are a novel source of amyloid peptide generation. Neurochemical research 34:2243\u20132250","journal-title":"Neurochem Res"},{"issue":"3","key":"2379_CR234","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1084\/jem.20171529","volume":"215","author":"WM Song","year":"2018","unstructured":"Song WM, Joshita S, Zhou Y, Ulland TK, Gilfillan S, Colonna M (2018) Humanized TREM2 mice reveal microglia-intrinsic and-extrinsic effects of R47H polymorphism. Journal of Experimental Medicine 215(3):745\u2013760","journal-title":"J Exp Med"},{"issue":"1","key":"2379_CR235","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0012-1606(81)80018-8","volume":"83","author":"WB Stallcup","year":"1981","unstructured":"Stallcup WB (1981) The NG2 antigen, a putative lineage marker: immunofluorescent localization in primary cultures of rat brain. Developmental biology 83(1):154\u2013165","journal-title":"Dev Biol"},{"key":"2379_CR236","doi-asserted-by":"publisher","unstructured":"Stallcup WB (2018) The NG2 proteoglycan in pericyte biology.\u00a0Pericyte Biology-Novel Concepts\u00a05-19.\u00a0https:\/\/doi.org\/10.1007\/978-3-030-02601-1_2","DOI":"10.1007\/978-3-030-02601-1_2"},{"key":"2379_CR237","doi-asserted-by":"crossref","unstructured":"Stallcup WB (2002) The NG2 proteoglycan: past insights and future prospects.\u00a0J Neurocytol\u00a031(6):423-ppl","DOI":"10.1023\/A:1025731428581"},{"issue":"3\u20134","key":"2379_CR238","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1017\/S1740925X09990342","volume":"5","author":"SM Staugaitis","year":"2009","unstructured":"Staugaitis SM, Trapp BD (2009) NG2-positive glia in the human central nervous system. Neuron Glia Biology 5(3\u20134):35\u201344","journal-title":"Neuron Glia Biol"},{"key":"2379_CR239","doi-asserted-by":"crossref","unstructured":"Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, ... Barres BA (2007) The classical complement cascade mediates CNS synapse elimination.\u00a0Cell\u00a0131(6):1164-1178","DOI":"10.1016\/j.cell.2007.10.036"},{"issue":"6","key":"2379_CR240","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0197-4580(01)00290-1","volume":"22","author":"WJ Streit","year":"2001","unstructured":"Streit WJ, Conde JR, Harrison JK (2001) Chemokines and Alzheimer\u2019s disease. Neurobiology of aging 22(6):909\u2013913","journal-title":"Neurobiol Aging"},{"key":"2379_CR241","doi-asserted-by":"crossref","unstructured":"Suridjan I, Pollock BG, Verhoeff NPLG, Voineskos AN, Chow T, Rusjan PM, ... Mizrahi R (2015) In-vivo imaging of grey and white matter neuroinflammation in Alzheimer\u2019s disease: a positron emission tomography study with a novel radioligand,[18F]-FEPPA.\u00a0Mol Psychiatry\u00a020(12):1579-1587","DOI":"10.1038\/mp.2015.1"},{"key":"2379_CR242","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s12031-019-01420-x","volume":"70","author":"M Talebi","year":"2020","unstructured":"Talebi M, Delpak A, Khalaj-Kondori M, Sadigh-Eteghad S, Talebi M, Mehdizadeh E, Majdi A (2020) ABCA7 and EphA1 genes polymorphisms in late-onset Alzheimer\u2019s disease. Journal of Molecular Neuroscience 70:167\u2013173","journal-title":"J Mol Neurosci"},{"issue":"3","key":"2379_CR243","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1096\/fj.201801670R","volume":"33","author":"E Tamburini","year":"2019","unstructured":"Tamburini E, Dallatomasina A, Quartararo J, Cortelazzi B, Mangieri D, Lazzaretti M, Perris R (2019) Structural deciphering of the NG2\/CSPG4 proteoglycan multifunctionality. The FASEB Journal 33(3):3112\u20133128","journal-title":"FASEB J"},{"issue":"s1","key":"2379_CR244","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.3233\/JAD-2012-129044","volume":"33","author":"RE Tanzi","year":"2013","unstructured":"Tanzi RE (2013) A brief history of Alzheimer\u2019s disease gene discovery. Journal of Alzheimer\u2019s disease 33(s1):S5\u2013S13","journal-title":"Int J Alzheimers Dis"},{"key":"2379_CR245","doi-asserted-by":"crossref","unstructured":"Thornton P, Sevalle J, Deery MJ, Fraser G, Zhou Y, St\u00e5hl S, ... Crowther DC (2017) TREM 2 shedding by cleavage at the H157\u2010S158 bond is accelerated for the Alzheimer\u2019s disease\u2010associated H157Y variant.\u00a0EMBO Mol Med\u00a09(10):1366-1378","DOI":"10.15252\/emmm.201707673"},{"key":"2379_CR246","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.bcp.2017.12.020","volume":"148","author":"T Trotta","year":"2018","unstructured":"Trotta T, Panaro MA, Cianciulli A, Mori G, Di Benedetto A, Porro C (2018) Microglia-derived extracellular vesicles in Alzheimer\u2019s disease: a double-edged sword. Biochemical pharmacology 148:184\u2013192","journal-title":"Biochem Pharmacol"},{"key":"2379_CR247","doi-asserted-by":"crossref","unstructured":"Trushina E, Nemutlu E, Zhang S, Christensen T, Camp J, Mesa J, ... Poduslo JF (2012) Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer\u2019s disease.\u00a0PloS one\u00a0\u00a07(2):e32737","DOI":"10.1371\/journal.pone.0032737"},{"key":"2379_CR248","doi-asserted-by":"crossref","unstructured":"Tsai AP, Lin PB, Dong C, Moutinho M, Casali BT, Liu Y, ... Nho K (2021) INPP5D expression is associated with risk for Alzheimer\u2019s disease and induced by plaque-associated microglia.\u00a0Neurobiol Dis\u00a0153:105303","DOI":"10.1016\/j.nbd.2021.105303"},{"key":"2379_CR249","doi-asserted-by":"crossref","unstructured":"Tsai AP, Dong C, Lin PB, Messenger EJ, Casali BT, Moutinho M, ... Nho K (2022) PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u2019s disease.\u00a0Genome Med\u00a014(1):17","DOI":"10.1186\/s13073-022-01022-0"},{"issue":"4","key":"2379_CR250","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1042\/BST20150058","volume":"43","author":"FE Turkheimer","year":"2015","unstructured":"Turkheimer FE, Rizzo G, Bloomfield PS, Howes O, Zanotti-Fregonara P, Bertoldo A, Veronese M (2015) The methodology of TSPO imaging with positron emission tomography. Biochemical Society Transactions 43(4):586\u2013592","journal-title":"Biochem Soc Trans"},{"key":"2379_CR251","doi-asserted-by":"crossref","unstructured":"Urayama S, Semi K, Sanosaka T, Hori Y, Namihira M, Kohyama J, ... Nakashima K (2013) Chromatin accessibility at a STAT3 target site is altered prior to astrocyte differentiation.\u00a0Cell\u00a0Struct Funct\u00a038(1):55-66","DOI":"10.1247\/csf.12034"},{"key":"2379_CR252","doi-asserted-by":"crossref","unstructured":"Vanzulli I, Papanikolaou M, De-La-Rocha IC, Pieropan F, Rivera AD, Gomez-Nicola D, ... Butt AM (2020) Disruption of oligodendrocyte progenitor cells is an early sign of pathology in the triple transgenic mouse model of Alzheimer\u2019s disease.\u00a0Neurobiol Aging\u00a094:130-139","DOI":"10.1016\/j.neurobiolaging.2020.05.016"},{"key":"2379_CR253","first-page":"173554","volume":"887","author":"M Vaz","year":"2020","unstructured":"Vaz M, Silvestre S (2020) Alzheimer\u2019s disease: recent treatment strategies. European journal of pharmacology 887:173554","journal-title":"Eur J Philos"},{"key":"2379_CR254","doi-asserted-by":"crossref","unstructured":"Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, ... Heneka MT (2017) Microglia-derived ASC specks cross-seed amyloid-\u03b2 in Alzheimer\u2019s disease.\u00a0Nature\u00a0552(7685):355-361","DOI":"10.1038\/nature25158"},{"issue":"3","key":"2379_CR255","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1046\/j.1471-4159.1997.68031135.x","volume":"68","author":"MM Verbeek","year":"1997","unstructured":"Verbeek MM, De Waal RM, Schipper JJ, Van Nostrand WE (1997) Rapid degeneration of cultured human brain pericytes by amyloid \u03b2 protein. Journal of neurochemistry 68(3):1135\u20131141","journal-title":"J Neurochem"},{"key":"2379_CR256","doi-asserted-by":"crossref","unstructured":"Verghese PB, Castellano JM, Garai K, Wang Y, Jiang H, Shah A, ... Holtzman DM (2013) ApoE influences amyloid-\u03b2 (A\u03b2) clearance despite minimal ApoE\/A\u03b2 association in physiological conditions. Proc Nat Acad Sci 110(19):E1807-E1816","DOI":"10.1073\/pnas.1220484110"},{"issue":"4","key":"2379_CR257","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.bbrc.2016.08.088","volume":"483","author":"A Verkhratsky","year":"2017","unstructured":"Verkhratsky A, Rodr\u00edguez-Arellano JJ, Parpura V, Zorec R (2017) Astroglial calcium signalling in Alzheimer\u2019s disease. Biochemical and biophysical research communications 483(4):1005\u20131012","journal-title":"Biochem Biophys Res Commun"},{"key":"2379_CR258","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.brainres.2015.09.012","volume":"1638","author":"F Vigan\u00f2","year":"2016","unstructured":"Vigan\u00f2 F, Dimou L (2016) The heterogeneous nature of NG2-glia. Brain research 1638:129\u2013137","journal-title":"Brain Res"},{"key":"2379_CR259","doi-asserted-by":"crossref","unstructured":"Vilalta A, Zhou Y, Sevalle J, Griffin JK, Satoh K, Allendorf DH, ... Brown GC (2021) Wild-type sTREM2 blocks A\u03b2 aggregation and neurotoxicity, but the Alzheimer\u2019s R47H mutant increases A\u03b2 aggregation.\u00a0J Biol Chem\u00a0296:10063","DOI":"10.1016\/j.jbc.2021.100631"},{"issue":"2","key":"2379_CR260","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4067\/S0716-97602001000200006","volume":"34","author":"R Von Bernhardi","year":"2001","unstructured":"Von Bernhardi R, Ramirez G (2001) Microglia\u2013astrocyte interaction in Alzheimer\u2019s disease: friends or foes for the nervous system? Biological Research 34(2):123\u2013128. https:\/\/doi.org\/10.4067\/S0716-97602001000200006","journal-title":"Biol Res"},{"issue":"7\u20138","key":"2379_CR261","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.neuint.2006.10.007","volume":"50","author":"HS Walton","year":"2007","unstructured":"Walton HS, Dodd PR (2007) Glutamate\u2013glutamine cycling in Alzheimer\u2019s disease. Neurochemistry international 50(7\u20138):1052\u20131066","journal-title":"Neurochem Int"},{"key":"2379_CR262","doi-asserted-by":"crossref","unstructured":"Wang C, Fan L, Khawaja RR, Liu B, Zhan L, Kodama L, ... Gan L (2022) Microglial NF-\u03baB drives tau spreading and toxicity in a mouse model of tauopathy.\u00a0Nat Commun\u00a013(1):1969","DOI":"10.1038\/s41467-022-29552-6"},{"key":"2379_CR263","doi-asserted-by":"crossref","unstructured":"Wang J, Qin X, Sun H, He M, Lv Q, Gao C, ... Liao H (2021) Nogo receptor impairs the clearance of fibril amyloid\u2010\u03b2 by microglia and accelerates Alzheimer\u2019s\u2010like disease progression.\u00a0Aging Cell\u00a020(12):e13515","DOI":"10.1111\/acel.13515"},{"issue":"1","key":"2379_CR264","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nature reviews neuroscience 17(1):22\u201335","journal-title":"Nat Rev Neurosci"},{"issue":"4","key":"2379_CR265","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-160763","volume":"57","author":"R Wang","year":"2017","unstructured":"Wang R, Reddy PH (2017) Role of glutamate and NMDA receptors in Alzheimer\u2019s disease. Journal of Alzheimer\u2019s Disease 57(4):1041\u20131048","journal-title":"J Alzheimer's Dis"},{"key":"2379_CR266","doi-asserted-by":"crossref","unstructured":"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, ... Colonna M (2020) Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model.\u00a0J Exp Med 217(9):e20200785","DOI":"10.1084\/jem.20200785"},{"key":"2379_CR267","doi-asserted-by":"crossref","unstructured":"Wessels AM, Tariot PN, Zimmer JA, Selzler KJ, Bragg SM, Andersen SW, ... Sims JR (2020) Efficacy and safety of lanabecestat for treatment of early and mild Alzheimer disease: the AMARANTH and DAYBREAK-ALZ randomized clinical trials.\u00a0JAMA Neurol\u00a077(2):199-209","DOI":"10.1001\/jamaneurol.2019.3988"},{"issue":"4","key":"2379_CR268","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/bpa.12152","volume":"24","author":"EA Winkler","year":"2014","unstructured":"Winkler EA, Sagare AP, Zlokovic BV (2014) The pericyte: a forgotten cell type with important implications for Alzheimer\u2019s disease? Brain pathology 24(4):371\u2013386","journal-title":"Brain Pathol"},{"issue":"20","key":"2379_CR269","doi-asserted-by":"publisher","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","volume":"93","author":"CM Wischik","year":"1996","unstructured":"Wischik CM, Edwards PC, Lai RY, Roth M, Harrington C (1996) Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proceedings of the National Academy of Sciences 93(20):11213\u201311218","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"2379_CR270","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1007\/s12031-022-02047-1","volume":"72","author":"J Wojcieszak","year":"2022","unstructured":"Wojcieszak J, Kuczy\u0144ska K, Zawilska JB (2022) Role of chemokines in the development and progression of Alzheimer\u2019s disease. Journal of Molecular Neuroscience 72(9):1929\u20131951","journal-title":"J Mol Neurosci"},{"issue":"6727","key":"2379_CR271","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/19077","volume":"398","author":"MS Wolfe","year":"1999","unstructured":"Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and \u03b3-secretase activity. Nature 398(6727):513\u2013517","journal-title":"Nature"},{"key":"2379_CR272","doi-asserted-by":"publisher","unstructured":"Wu C, Zou P, Zhu L, Feng S, Deng Q, Liu TCY, ... Yang L (2025) Treadmill exercise mitigates Alzheimer\u2019s pathology by modulating glial polarization and reducing oligodendrocyte precursor cell perivascular clustering.\u00a0Med Sci Sports Exerc.\u00a0https:\/\/doi.org\/10.1249\/MSS.0000000000003650","DOI":"10.1249\/MSS.0000000000003650"},{"issue":"46","key":"2379_CR273","doi-asserted-by":"publisher","first-page":"33027","DOI":"10.1074\/jbc.M113.517540","volume":"288","author":"P Wunderlich","year":"2013","unstructured":"Wunderlich P, Glebov K, Kemmerling N, Tien NT, Neumann H, Walter J (2013) Sequential proteolytic processing of the triggering receptor expressed on myeloid cells-2 (TREM2) protein by ectodomain shedding and \u03b3-secretase-dependent intramembranous cleavage. Journal of Biological Chemistry 288(46):33027\u201333036","journal-title":"J Biol Chem"},{"issue":"3","key":"2379_CR274","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","volume":"35","author":"T Wyss-Coray","year":"2002","unstructured":"Wyss-Coray T, Mucke L (2002) Inflammation in neurodegenerative disease\u2014a double-edged sword. Neuron 35(3):419\u2013432","journal-title":"Neuron"},{"issue":"1","key":"2379_CR275","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3109\/13550289909029743","volume":"5","author":"M Xia","year":"1999","unstructured":"Xia M, Hyman BT (1999) Chemokines\/chemokine receptors in the central nervous system and Alzheimer\u2019s disease. Journal of neurovirology 5(1):32\u201341","journal-title":"J Neurovirol"},{"key":"2379_CR276","doi-asserted-by":"crossref","unstructured":"Xiao L, Ohayon D, McKenzie IA, Sinclair-Wilson A, Wright JL, Fudge AD, ... Richardson WD (2016) Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning.\u00a0Nat Neurosci\u00a019(9):1210-1217","DOI":"10.1038\/nn.4351"},{"issue":"27","key":"2379_CR277","doi-asserted-by":"publisher","first-page":"e2023418118","DOI":"10.1073\/pnas.2023418118","volume":"118","author":"Y Xu","year":"2021","unstructured":"Xu Y, Propson NE, Du S, Xiong W, Zheng H (2021) Autophagy deficiency modulates microglial lipid homeostasis and aggravates tau pathology and spreading. Proceedings of the National Academy of Sciences 118(27):e2023418118","journal-title":"Proc Natl Acad Sci"},{"key":"2379_CR278","unstructured":"y Cajal R (1913) Contribuci\u00f3n al conocimiento de la neuroglia del cerebro humano. Trab Lab Invest Biol 11:255"},{"key":"2379_CR279","doi-asserted-by":"crossref","unstructured":"Yang J, Zhang R, Shi C, Mao C, Yang Z, Suo Z, ... Xu Y (2017) AQP4 association with amyloid deposition and astrocyte pathology in the Tg-ArcSwe mouse model of Alzheimer\u2019s disease. J\u00a0 Alzheimers Dis 57(1):157-169","DOI":"10.3233\/JAD-160957"},{"issue":"4978","key":"2379_CR280","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1126\/science.2218531","volume":"250","author":"BA Yanker","year":"1990","unstructured":"Yanker BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250(4978):279\u2013282. https:\/\/doi.org\/10.1126\/science.2218531","journal-title":"Science"},{"key":"2379_CR281","doi-asserted-by":"crossref","unstructured":"Yasuno F, Kosaka J, Ota M, Higuchi M, Ito H, Fujimura Y, ... Suhara T (2012) Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment\u2013dementia converters measured by positron emission tomography with [11C] DAA1106.\u00a0Psychiatry Res Neuroimaging\u00a0203(1):67-74","DOI":"10.1016\/j.pscychresns.2011.08.013"},{"key":"2379_CR282","doi-asserted-by":"crossref","first-page":"117957352090739","DOI":"10.1177\/1179573520907397","volume":"12","author":"KG Yiannopoulou","year":"2020","unstructured":"Yiannopoulou KG, Papageorgiou SG (2020) Current and future treatments in Alzheimer disease: an update. Journal of central nervous system disease 12:1179573520907397","journal-title":"J Central Nerv Syst Dis"},{"key":"2379_CR283","doi-asserted-by":"crossref","unstructured":"Yokokura M, Mori N, Yagi S, Yoshikawa E, Kikuchi M, Yoshihara Y, ... Ouchi Y (2011) In vivo changes in microglial activation and amyloid deposits in brain regions with hypometabolism in Alzheimer\u2019s disease.\u00a0Eur J Nucl Med Mol Imaging 38:343-351","DOI":"10.1007\/s00259-010-1612-0"},{"key":"2379_CR284","unstructured":"Yoshida M (2013) Neuropathology of tauopathy.\u00a0Brain and Nerve= Shinkei Kenkyu no Shinpo\u00a065(12):1445-1458"},{"key":"2379_CR285","doi-asserted-by":"crossref","unstructured":"Young KM, Psachoulia K, Tripathi RB, Dunn SJ, Cossell L, Attwell D, ... Richardson WD (2013) Oligodendrocyte dynamics in the healthy adult CNS: evidence for myelin remodeling.\u00a0Neuron\u00a077(5):873-885","DOI":"10.1016\/j.neuron.2013.01.006"},{"issue":"1","key":"2379_CR286","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1146\/annurev-neuro-071013-014300","volume":"37","author":"JT Yu","year":"2014","unstructured":"Yu JT, Tan L, Hardy J (2014) Apolipoprotein E in Alzheimer\u2019s disease: an update. Annual review of neuroscience 37(1):79\u2013100","journal-title":"Ann Rev Neurosci"},{"issue":"10","key":"2379_CR287","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/cr.2016.85","volume":"26","author":"QC Yu","year":"2016","unstructured":"Yu QC, Song W, Wang D, Zeng YA (2016) Identification of blood vascular endothelial stem cells by the expression of protein C receptor. Cell research 26(10):1079\u20131098","journal-title":"Cell Res"},{"key":"2379_CR288","doi-asserted-by":"crossref","unstructured":"Zhang P, Kishimoto Y, Grammatikakis I, Gottimukkala K, Cutler RG, Zhang S, ... Mattson MP (2019) Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model.\u00a0Nat Neurosci\u00a022(5):719-728","DOI":"10.1038\/s41593-019-0372-9"},{"issue":"1","key":"2379_CR289","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L (2024) Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal transduction and targeted therapy 9(1):211","journal-title":"Signal Transduct Target Ther"},{"key":"2379_CR290","doi-asserted-by":"crossref","unstructured":"Zhang X, Zou L, Tang L, Xiong M, Yan XX, Meng L, ... Zhang Z (2024) Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice.\u00a0Plos Biol\u00a022(1):e3002470","DOI":"10.1371\/journal.pbio.3002470"},{"key":"2379_CR291","doi-asserted-by":"crossref","unstructured":"Zhao P, Xu Y, Jiang L, Fan X, Li L, Li X, ... An Z (2022) A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer\u2019s disease.\u00a0Sci Transl Med\u00a014(661):eabq0095","DOI":"10.1126\/scitranslmed.abq0095"},{"issue":"4","key":"2379_CR292","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1242\/dev.047951","volume":"138","author":"X Zhu","year":"2011","unstructured":"Zhu X, Hill RA, Dietrich D, Komitova M, Suzuki R, Nishiyama A (2011) Age-dependent fate and lineage restriction of single NG2 cells. Development 138(4):745\u2013753","journal-title":"Development"},{"key":"2379_CR293","doi-asserted-by":"crossref","unstructured":"Zilberter M, Ivanov A, Ziyatdinova S, Mukhtarov M, Malkov A, Alp\u00e1r A, ... Zilberter Y (2013) Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer\u2019s disease.\u00a0J Neurochem 125(1):157-171","DOI":"10.1111\/jnc.12127"},{"key":"2379_CR294","doi-asserted-by":"crossref","unstructured":"Zhong L, Xu Y, Zhuo R, Wang T, Wang K, Huang R, ... Chen XF (2019) Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer\u2019s disease model.\u00a0Nat Commun\u00a010(1):1365","DOI":"10.1038\/s41467-019-09118-9"},{"key":"2379_CR295","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s12035-014-8723-8","volume":"51","author":"XC Zhu","year":"2015","unstructured":"Zhu XC, Yu JT, Jiang T, Wang P, Cao L, Tan L (2015) CR1 in Alzheimer\u2019s disease. Molecular neurobiology 51:753\u2013765","journal-title":"Mol Neurobiol"},{"key":"2379_CR296","doi-asserted-by":"crossref","unstructured":"Zou P, Wu C, Liu TC, Duan R, Yang L (2023) Oligodendrocyte progenitor cells in Alzheimer\u2019s disease: from physiology to pathology.). Transl Neurodegen 12(1):52","DOI":"10.1186\/s40035-023-00385-7"},{"issue":"1","key":"2379_CR297","first-page":"52","volume":"12","author":"P Zou","year":"2023","unstructured":"Zou P, Wu C, Liu TCY, Duan R, Yang L (2023) Oligodendrocyte progenitor cells in Alzheimer\u2019s disease: from physiology to pathology. Translational neurodegeneration 12(1):52","journal-title":"Transl Neuropharmacol"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-025-02379-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12031-025-02379-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-025-02379-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T15:24:25Z","timestamp":1759764265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12031-025-02379-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":297,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["2379"],"URL":"https:\/\/doi.org\/10.1007\/s12031-025-02379-8","relation":{},"ISSN":["1559-1166"],"issn-type":[{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"12 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}